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Abstract 
Mass Spectrometry Imaging (MSI) has become an indispensable tool for studying the 
spatial distribution of molecules within a diverse range of complex biological samples. 
It exploits the advantages of modern mass spectrometers including enhanced 
sensitivity, mass accuracy, and resolving power to produce images that visually 
represent tissue biology. This contributes to the understanding of complex biochemical 
processes by revealing the identity of molecular entities and their tissue distribution. 
Since the introduction of MSI, Matrix-Assisted Laser Desorption Ionization (MALDI) 
has become a dominant imaging method of MS, which proved its usefulness to sort out 
the complexity of lipid structures in biological tissues. Lipids are particularly suitable 
for MALDI MSI because they are abundant components of biological tissues, they 
ionize easily due to their polar head groups, and their molecular weights are generally 
below 1000 Da, which is optimal for sensitive and high resolution mass analysis. 
The mapping of tissue lipids by MSI contributed to the understanding of 
pathophysiological changes associated with different therapeutic treatments or disease 
evolution. One example where this aspect could be particularly useful is the toxicity 
mechanisms of platinum-based therapeutics including the antitumor drug, cisplatin. The 
role of cisplatin in the treatment of several human malignancies is well-established. 
However, nephrotoxicity is a limiting side effect that hinders the use of higher doses to 
maximize its antineoplastic effects. Cisplatin-induced nephrotoxicity involves an acute 
injury of the proximal tubule, where renal accumulation of cisplatin was found. Also 
increased lipid peroxidation and impaired cell membrane integrity with altered lipid 
profile of the kidney were reported. 
Previous works have shown that lipid imaging in kidney helped distinguish specific 
lipids within the kidney substructures and identify alterations occurring during kidney 
diseases. This evolved the motivation to map the lipid composition of the kidney tissue 
in cisplatin-treated rats to shed light on the lipid alterations occurring in cisplatin-
induced nephrotoxicity and the biochemical and pathophysiological processes 
involved. 
In the first part of this work, a robust method for imaging of lipids in rat kidney sections 
using MALDI-LTQ-Orbitrap was developed. To enhance the method sensitivity, 
    
 
 
evaluating the matrix compound of choice and optimizing the deposition of the matrix 
solution were considered. Following the developed method, imaging measurements of 
kidney sections of healthy control and cisplatin-treated rats were performed utilizing 
the high performance of the Orbitrap mass analyzer. Its high mass resolution and 
accuracy enabled database assignment of the lipid species based on their exact mass. 
The identification of lipids was confirmed by on-tissue MS/MS followed by fragment 
ion imaging. The distribution comparison of renal lipids in control and cisplatin-treated 
tissues revealed clear differences, which could be correlated to the proximal tubule 
injury. The findings highlight the usefulness of MALDI MSI as potential 
complementary tool for clinical diagnostics, which might contribute to the 
understanding of lipid signaling pathways and mechanisms involved in cisplatin-
associated nephrotoxicity. 
However, the demonstrated differences in the distribution of kidney lipids in control 
and cisplatin-treated groups have mainly considered qualitative aspects. The use of ion 
images for reliable intersample comparison on relative quantitative basis was limited 
by the variable influence of experimental and instrumental conditions. In addition, 
sample-originated matrix effects including tissue surface microenvironment, result in 
inhomogeneous matrix-analyte crystal formation. Consequently, non-linear variability 
in extraction, desorption and ionization of analytes across the tissue could be found. 
Accordingly, the challenge to develop a method for normalization of lipid signals in 
kidney tissues, arose. The work strategy was designed with the aim to allow relative 
quantitative comparison of lipid intensity in MALDI imaging measurements of 
different kidney samples. It utilized a mixture of the MALDI matrix and dual lipid-
metal internal standards. To ensure homogenous and reproducible deposition, the 
mixture was automatically applied by means of a commercially available inkjet printer, 
avoiding expensive matrix deposition devices. The lipid internal standard was used to 
normalize the signal intensity of tissue lipids, whereas the metal internal standard 
allowed to confirm the consistency of the matrix and internal standards application. The 
latter being monitored by total metal content determination using inductively-coupled 
plasma mass spectrometry (ICP-MS). Normalization of lipids signals demonstrated 
excellent image correction with respect to variability of laser energy deposition 
observed in MALDI tissue imaging measurements. Applying the method to normalize 
    
 
 
ion intensities of kidney lipids in control and cisplatin-treated rats successfully enabled 
the comparison of lipid images in both groups on relative quantitative basis.  
The results conclude the ICP-MS-controlled application of matrix and internal 
standards as crucial, when relative quantitative comparison of MALDI MSI data is 
intended. They also foresee the use of multimolecular internal standards extended to a 
wider range of lipid classes to be of great potential for MALDI imaging of tissue lipids, 
enabling improved pixel-based normalization of different lipid species simultaneously.  
    
 
 
Zusammenfassung 
Massenspektrometrie Imaging (MSI) hat sich zu einem unverzichtbaren Werkzeug für 
die Untersuchung der räumlichen Verteilung von Molekülen in einer Vielzahl von 
komplexen biologischen Proben entwickelt. Es nutzt die Vorteile moderner 
Massenspektrometer einschließlich verbesserter Empfindlichkeit, Massengenauigkeit 
und Auflösungsvermögen, um Bilder zu erzeugen, die Gewebebiologie visuell 
darstellen. Dies trägt zum Verständnis komplexer biochemischer Prozesse bei, indem 
es die Identität von molekularen Einheiten und deren Gewebeverteilung aufdeckt. 
Seit der Einführung von MSI ist die Matrix-unterstützte Laser-Desorption Ionisation 
(MALDI) zu einer dominierenden Bildgebungsmethode der MS geworden, die sich als 
nützlich erwiesen hat, um die Komplexität von Lipidstrukturen in biologischen 
Geweben zu bestimmen. Lipide sind besonders  für MALDI-MSI geeignet, da sie 
Bestandteile von vielen biologischen Geweben sind, sie aufgrund ihrer polaren 
Kopfgruppen leicht zu  ionisieren sind und ihr Molekulargewicht im Allgemeinen unter 
1000 Da liegt, was für eine empfindliche und hochauflösende Massenanalyse optimal 
ist. 
Die Kartierung von Gewebslipiden durch MSI trägt zum Verständnis von 
pathophysiologischen Veränderungen bei, die mit verschiedenen therapeutischen 
Behandlungen oder der Krankheitsentwicklung zusammenhängen. Ein Beispiel, bei 
dem dieser Aspekt besonders nützlich sein könnte, sind die Toxizitätsmechanismen von 
Therapeutika auf Platinbasis einschließlich des Antitumorwirkstoffs Cisplatin. Die 
Rolle von Cisplatin bei der Behandlung von mehreren malignen Erkrankungen beim 
Menschen ist gut etabliert. Die Nephrotoxizität ist jedoch ein begrenzender 
Nebeneffekt, der die Verwendung höherer Dosen zur Maximierung ihrer 
antineoplastischen Wirkungen verhindert. Cisplatin-induzierte Nephrotoxizität 
beinhaltet eine akute Verletzung des proximalen Tubulus, wo Nierenakkumulation von 
Cisplatin gefunden wurde. Auch erhöhte Lipidperoxidation und gestörte 
Zellmembranintegrität mit verändertem Lipidprofil der Niere wurden berichtet. 
Frühere Arbeiten haben gezeigt, dass Lipid-Bildgebung in der Niere dabei hilft, 
bestimmte Lipide innerhalb der Nierensubstrukturen zu unterscheiden und 
Veränderungen zu identifizieren, die während der Nierenerkrankungen auftreten. Dies 
    
 
 
entwickelte die Motivation, die Lipidzusammensetzung des Nierengewebes in 
Cisplatin-behandelten Ratten zu kartieren, um Licht auf die Lipidveränderungen zu 
werfen, die in Cisplatin-induzierter Nephrotoxizität und den beteiligten biochemischen 
und pathophysiologischen Prozessen auftreten. 
Im ersten Teil dieser Arbeit wurde eine robuste Methode zur Darstellung von Lipiden 
in Rattennierenschnitten mit MALDI-LTQ-Orbitrap entwickelt. Um die Sensitivität der 
Methode zu verbessern, wurde die Matrixverbindung der Wahl untersucht und die 
Abscheidung der Matrixlösung optimiert. Nach dem entwickelten Verfahren wurden 
bildgebende Messungen von Nierenschnitten gesunder Kontroll- und Cisplatin-
behandelter Ratten unter Verwendung der hohen Leistung des Orbitrap-
Massenanalysators durchgeführt. Dessen hohe Massenauflösung und Genauigkeit 
ermöglichte die Datenbankzuordnung der Lipidspezies basierend auf ihrer genauen 
Masse. Die Identifizierung von Lipiden wurde durch MS / MS im Gewebe, gefolgt von 
Fragment-Ionen-Bildgebung, bestätigt. Der Verteilungsvergleich der Nierenlipide in 
Kontroll- und Cisplatin-behandelten Geweben zeigte deutliche Unterschiede, die mit 
der proximalen Tubulusverletzung korreliert werden konnten. Die Ergebnisse 
unterstreichen die Nützlichkeit von MALDI MSI als potentielles komplementäres 
Werkzeug für die klinische Diagnostik, das zum Verständnis von Lipid-Signalwegen 
und Mechanismen, die an Cisplatin-assoziierter Nephrotoxizität beteiligt sind, 
beitragen könnte. 
Die nachgewiesenen Unterschiede in der Verteilung von Nierenlipiden in Kontroll- und 
Cisplatin-behandelten Gruppen haben jedoch hauptsächlich qualitative Aspekte 
berücksichtigt. Die Verwendung von Ionenbildern für einen zuverlässigen Vergleich 
zwischen Proben auf relativer quantitativer Basis wurde durch den variablen Einfluss 
von experimentellen und instrumentellen Bedingungen begrenzt. Darüber hinaus 
führen aus den Proben stammende Matrixeffekte, einschließlich der Mikroumgebung 
der Gewebeoberfläche, zu einer inhomogenen Matrix-Analyt-Kristallbildung. Folglich 
konnte eine nichtlineare Variabilität bei der Extraktion, Desorption und Ionisierung von 
Analyten im Gewebe gefunden werden. 
Dementsprechend bestand die Herausforderung, ein Verfahren zur Normalisierung von 
Lipidsignalen in Nierengeweben zu entwickeln. Die Arbeitsstrategie wurde mit dem 
Ziel entwickelt, einen relativen quantitativen Vergleich der Lipidintensität in MALDI-
    
 
 
Bildgebungs-Messungen verschiedener Nierenproben zu ermöglichen. Es verwendete 
eine Mischung aus der MALDI-Matrix und zwei Lipid-Metall-internen Standards. Um 
eine homogene und reproduzierbare Abscheidung zu gewährleisten, wurde die 
Mischung automatisch mittels eines handelsüblichen Tintenstrahldruckers aufgebracht, 
wobei teure Matrixabscheidungsvorrichtungen vermieden wurden. Der interne 
Lipidstandard wurde verwendet, um die Signalintensität von Gewebslipiden zu 
normalisieren, während der interne Metallstandard die Konsistenz der Matrix und die 
Anwendung interner Standards bestätigte. Letzteres wird durch Bestimmung des 
Gesamtmetallgehalts unter Verwendung von Massenspektrometrie mit induktiv 
gekoppeltem Plasma (ICP-MS) überwacht. Die Normalisierung der Lipidsignale zeigte 
eine ausgezeichnete Bildkorrektur in Bezug auf die Variabilität der 
Laserenergieablagerung, die bei MALDI-Gewebebildgebungsmessungen beobachtet 
wurde. Die Anwendung der Methode zur Normalisierung der Ionenintensitäten von 
Nierenlipiden in Kontroll- und Cisplatin-behandelten Ratten ermöglichte den Vergleich 
von Lipidbildern in beiden Gruppen auf relativer quantitativer Basis. 
Die Ergebnisse schließen die ICP-MS-kontrollierte Anwendung von Matrix- und 
internen Standards als entscheidend ab, wenn ein relativer quantitativer Vergleich von 
MALDI-MSI-Daten beabsichtigt ist. Sie sehen auch die Verwendung von 
multimolekularen internen Standards, die auf einen breiteren Bereich von Lipidklassen 
erweitert werden, als großes Potenzial für die MALDI-Bildgebung von Gewebslipiden 
vor, was eine verbesserte pixelbasierte Normalisierung verschiedener Lipidspezies 
gleichzeitig ermöglicht. 
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1 Introduction 
1.1 Mass Spectrometry Imaging - MSI 
Mass Spectrometry Imaging (MSI) is an innovative development of mass spectrometry 
which emerged as a promising technique in many areas, including biomedical sciences, 
material sciences and forensics, owing to its high chemical specificity and relative ease 
of application[1-3]. MSI techniques were introduced into the biological sciences at the 
end of the 20th century[4], since then it has witnessed numerous methodological and 
technological developments and positioned itself in the focus of mainstream mass 
spectrometry (MS). 
MSI could be defined as a label-free molecular imaging technique, which allows in situ 
analysis of molecules in complex biological samples. It provides high-resolution 
images of biomolecules directly from tissue sections utilizing two important features. 
The first is the chemical specificity of mass spectrometry, which allows determining 
the mass of biomolecules (m/z) without prior labelling commonly required for other 
imaging techniques, such as fluorescence, radioimmunoassays, among others. 
Secondly, the spatial arrangement of biomolecules in the measured sample could be 
indicated, allowing visualization of molecular distribution. Hence, MSI made possible 
the direct identification and localization of a wide range of molecules, including 
pharmaceuticals, metabolites, lipids, proteins, and peptides on the surfaces of various 
types of complex samples, in a scale range extending from subcellular dimensions to 
whole biological systems. 
In principle, the imaging process in biological research is carried out by rastering a 
mass spectrometric microprobe across the sample surface in a predefined pattern. Each 
spot at which the probe is fired, biomolecules are desorbed and ionized from the surface 
and a mass spectrum is created, which is stored along with its relative position[5]. Once 
acquisition is complete, imaging software is employed to create MS images, in which 
individual ions can be extracted and displayed as a function of intensity versus relative 
position, where changes in color represent changes in intensity. The general principle 
of a typical MSI experiment is illustrated in Figure 1. 
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Figure 1. General principle of MSI methods. (a) In a typical MSI experiment, the 
total area is theoretically subdivided into pixels that are individually inspected (1 and 
2 represent the steps desorption and ionization process). (b) For each pixel a single 
mass spectrum or the average of several mass spectra is collected and stored together 
with its spatial coordinates. (c) After the entire surface is scanned, an average mass 
spectrum can be created. The distribution of specific ions can be visualized by the 
creation of chemical images where the color scale (false color) represents the 
normalized intensity of particular ions. Each pixel from the image is associated with 
the original mass spectrum/spectra acquired at the specific point. (d) The aim of 
imaging is to display the distribution of chemicals across a surface. (Adapted from 
Wu et al.[1]) 
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A number of desorption and ionization techniques have been introduced in MSI studies 
of biological samples. The most established ones are matrix assisted laser desorption 
ionization (MALDI), desorption electrospray ionization (DESI), and secondary ion 
mass spectrometry (SIMS). Other emerging techniques in MSI exist, which are mostly 
derivatives or modifications of the major methods listed above, such as nano-DESI, 
laser ablation electrospray ionization (LAESI), and liquid extraction surface analysis 
(LESA)[6, 7]. Also, laser ablation inductively coupled plasma MS (LA-ICP-MS) is one 
of the desorption and ionization techniques that is gaining popularity for MSI. This 
technique is capable of quantitative imaging of elemental distributions generated from 
surfaces[3].  
Irrespective of the imaging modality, MSI could be generally described as a three-step 
process which involves sample preparation, data acquisition, and data analysis[1, 3]. 
All three components should be controlled and optimized to obtain meaningful MSI 
data. In the following, the three components of MSI are briefly described.  
Sample preparation aims mainly at maintaining the integrity and the spatial 
arrangement of the molecular species within the biological sample. Collection and 
treatment procedures need to be sufficiently fast to prevent tissue degradation. It is 
worth to state that sample preparation varies largely depending on the ionization 
technique. DESI and SIMS require minimal sample preparation, whereas MALDI 
implies application of the matrix, as will be discussed later with respect to each 
ionization method. MSI studies reported the use of various types of biological samples, 
including single cells[8-11] bacterial colonies[12, 13], tissues from different plants[14-
17] or animal organs[18, 19] and rodent whole body sections[20-23]. Samples might 
be fresh, snap-frozen[24], alcohol preserved[25], or formalin-fixed paraffin-embedded 
(FFPE)[26]. 
Data acquisition involves the stages of desorption/ionization, mass analysis and ion 
detection (Figure 1a, b). Desorption and ionization of molecules from the sample 
surface could be achieved using a laser beam in case of MALDI, a primary ion beam in 
case of SIMS, or a charged droplet flux in case of DESI (Figure 2). 
In MSI, data acquisition is either performed in the microprobe mode or the microscope 
mode. The microprobe mode is by far more frequently used. In this approach, the 
surface of the sample is theoretically divided into small areas (pixels). All pixels are 
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scanned individually in sequence by the desorption/ionization probe, which is adjusted 
to provide the desired spatial resolution. The data collected from each pixel is 
represented in a mass spectrum or an average of two or more mass spectra acquired 
from the specific spot[3]. The alternative microscope mode makes use of astigmatic 
projection of ions generated at the sample surface to a position-sensitive (two-
dimensional) detector, which allows the simultaneous imaging of a larger area. This 
method allows higher speed of analysis, but the specific ion optics required and the 
restriction to perform imaging under vacuum conditions limits its application[1]. 
The ionized molecules are subsequently directed into the mass analyzer where they are 
separated and detected according to their m/z ratio. Several types of mass analyzers can 
be interfaced with these desorption and ionization sources including Time Of Flight 
(TOF), Fourier Transform Ion Cyclotron Resonance (FTICR), linear triple quadrupole, 
quadrupole ion-trap, or Orbitrap[3]. 
Data collected from MSI yield high resolution molecular profiles across the tissue. 
Datasets can contain hundreds to thousands of peaks with data files of up to a few 
gigabytes[27], which requires complex visualization software. MSI software has been 
developed to control data processing in order to generate ion images, minimize manual 
investigation, and provide standardized protocols for routine analysis[3, 28]. 
FlexImaging and ImageQuest are examples of commercial MSI software, while 
Biomap, Image J, MSiReader are freely available sources. 
 
Figure 2. Working principle of different ionization sources in MSI. (A) Desorption 
electrospray ionization (DESI), (B) matrix-assisted laser desorption/ionization 
(MALDI), and (C) secondary ion mass spectrometry (SIMS). (Adapted from Addie 
et al.[7]) 
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1.2 Desorption and ionization techniques in MSI 
A recent survey conducted within MSI practitioners showed that MALDI is by far the 
most utilized technique, while DESI and SIMS are significantly less popular[29]. This 
section presents an overview on the three molecular MSI methods mentioned above. A 
brief overview of SIMS and DESI is followed by a detailed discussion of MALDI 
which is the MSI technique used in this work. In addition, a short description of the 
elemental MSI method, laser-ablation-inductively coupled plasma (LA-ICP), is given.  
1.2.1 Secondary Ion Mass Spectrometry - SIMS 
SIMS is a desorption and ionization technique used for MSI which utilizes a primary 
ion beam (e.g. metal ions) to produce secondary ions from the surface of the sample. 
The surface of the sample under high vacuum is bombarded with a high energy primary 
ion beam (typically 5-25 keV)[30]. This primary ion beam can be focused as sharply as 
50 nm or less, depending on the primary ion beam current and the charge state of the 
primary ions[3]. A collisional cascade within ≈ 10 nm of the surface is initiated. The 
energy transfer to the molecules deposited on the surface causes their extensive 
fragmentation, since the energy of primary ions is substantially high compared with 
bond energies of the surface molecules. 
When moving away from the primary collision site, less fragmentation occurs and a 
small fraction of intact molecules is subsequently ejected from the first layers of the 
surface if the surface binding energy is overcome. Most molecules are emitted as 
neutrals and only approximately 1% of them are charged, which are called the 
secondary ions[30]. Both negative and positive secondary ions can be generated 
depending on the electron configuration of the surface molecules. Primary ions could 
be either monoatomic (Ar+, Ga+, In+, Au+, Bi+) or polyatomic (C60+, Bi3+, Aun+)[31, 32]. 
The latter are considered softer allowing desorption of secondary ions from the sample 
surface without extensive fragmentation (softer). Consequently, polyatomic ion beams 
are more suitable for the analysis of intact biomolecules from tissue surfaces and their 
applications extend to larger molecular weight species[2, 33]. 
The sample preparation protocol for the SIMS imaging experiment requires only 
mounting of the tissue section on conductive surface (e.g. indium tin oxide (ITO)-
coated glass slide), without further washing steps. 
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The sample must be stable under high vacuum conditions, which ensures that both the 
primary and secondary ions travel from their origin to their final destination without 
undergoing collisions[3]. Due to its excellent spatial resolution capabilities, SIMS 
applications extended to imaging studies of small biomolecules in unicellular 
organisms[33], single cells[34], embryos[35], and different organs such as kidney[36] 
and brain[37]. Limitations of SIMS include the lack of sensitivity of the mass range 
over 1000 m/z, due to in-source fragmentation of complex molecules. This also results 
in complex mass spectra which might be difficult to interpret. In addition, commercially 
available SIMS instruments have limited capability of molecules identification because 
they have neither the capacity to perform MS/MS fragmentation, nor they provide 
sufficient mass resolution required for high-resolution imaging[30, 38, 39]. 
1.2.2 Desorption Electrospray Ionization - DESI 
The relatively new ionization method developed by R.G. Cooks in 2004[40], DESI, 
belongs to the ambient ionization methods, in which ionization occurs at atmospheric 
pressure with the samples being analyzed in their native state[41].  
DESI is a combination of two MS ionization methods: electrospray ionization (ESI) 
and desorption ionization (DI). It uses energetic charged electrospray solvent droplets 
to desorb the molecules from the sample surface. 
As the charged droplets strike the sample surface, they extract surface-bound analytes 
that are then desorbed from the surface within scattered secondary droplets. Upon 
solvent evaporation, these droplets lead to the formation of intact analyte ions that are 
transported from the surface into the MS inlet[42]. The ionization of biomolecules in 
DESI takes place in a manner similar to ESI, hence, the soft ionization yields analyte 
ions with minimal fragmentation which could be multiply charged. The analysis is 
usually limited to a mass range of 2000 Da and a lateral resolution of about 50 µm[43]. 
Advantages of DESI include ambient analysis conditions and the possibility to perform 
tandem mass spectrometry (MS/MS) and accurate mass measurements, which allows 
the identification of analytes. In addition, DESI – like SIMS – requires minimal sample 
preparation, which could be problematic leading to analyte delocalization or chemical 
modification of endogenous compounds[1]. On the other hand, a limitation of DESI is 
the physical damage encountered by biological samples on a microscopic scale during 
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DESI imaging, when a conventional solvent system such as MeOH:H2O is used. 
Depletion of tissue samples was necessary to obtain sustainable abundant signals and 
high quality images of biomolecules in tissues[44]. Nevertheless, recently developed 
solvent systems such as ACN:DMF and EtOH:DMF (1:1) have shown to provide 
abundant signal and high quality DESI images for lipids while preserving tissue 
morphology and protein content of biological tissues. These non-aqueous 
‘‘morphologically friendly” solvent systems are non-destructive allowing analysis in 
sequence using immunohistochemistry and MALDI imaging to be performed on the 
same tissue section after DESI-MS imaging[45]. Recent DESI applications include the 
profiling of lipids for characterization of tumorigenesis[46], the analysis of colorectal 
adenocarcinoma tissue[47], and the study of endogenous and drug metabolites[48]. 
1.2.3 Matrix-Assisted Laser Desorption Ionization - MALDI 
Biomolecular imaging using MALDI was first described in 1994 by Spengler et al.[49] 
and later in more details in 1997 by Caprioli et al.[4], nowadays it is the most widely 
used MSI method[38]. It is a soft ionization technique that is capable of producing intact 
higher molecular weight ions using a pulsed laser beam combined with energy 
absorbing matrix molecules. 
An outline of the technique goes typically as follows (Figure 3); a matrix solution is 
applied to cover the sample surface, which is commonly a thin tissue section. The 
matrix, which is a low molecular weight organic compound possessing suitable 
chromophores to absorb the energy of UV laser beam, is usually applied in high excess 
relative to the concentration of surface analytes. On-tissue application of the matrix 
solution results in in-situ extraction of biomolecules from the sample surface. 
Subsequently, evaporation of the solvent causes crystallization of the matrix molecules 
and incorporation of analyte biomolecules into the formed crystals. As the laser beam 
irradiates the sample surface, the matrix crystals absorb the majority of the laser energy, 
leading to explosive desorption of the matrix crystals, incorporating the analyte into the 
gas phase without its degradation. The matrix facilitates the ionization of analyte 
molecules in the gas phase as well. For each location where the laser hits the sample 
surface, mass signals of the desorbed ions are acquired in a mass spectrum. A data set 
consisting of an ordered array of mass spectra is created, where each spectrum 
represents the local molecular composition at known x,y coordinates. The intensities of 
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the molecular masses (m/z values) of specific compounds in each spectrum can be 
extracted to produce images showing the localization of the molecules within the 
tissue[39]. 
 
Figure 3. Overview of the MALDI IMS workflow on a section of a human kidney 
biopsy. (a) Fresh frozen tissue is cut and mounted on a glass slide. Matrix is applied 
by a robotic sprayer or is sublimated, and the section is irradiated by the laser in a 
raster array. (b) Mass spectra are acquired for each x,y coordinate. (c) Selected ions 
may be mapped on the tissue surface to create ion images. (Adapted from Gessel et 
al. [50]) 
This section overviews the MALDI MSI pipeline, including sample preparation, matrix 
selection and application, desorption and ionization processes, lasers, mass analyzers, 
and data processing. Finally, applications of MALDI for biomolecular imaging are 
discussed. 
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Sample preparation  
Sample preparation pipeline encompasses all handling of the samples starting with 
collection until analysis. Developing sample preparation protocols aims mainly at 
maintaining the spatial integrity of biomolecules in the sample. Variation in sample 
preparation results in variation in ion generation, hence careful optimization is 
necessary to maintain sensitivity, accuracy and reproducibility of the analysis. Sample 
preparation includes collection (cutting, mounting, storage), processing (washing, 
digestion, derivatization), and finally matrix application. The work in this thesis 
exclusively uses tissue sections of animal origin. Hence, the most common procedures 
for sample preparation with respect to animal tissues are discussed. 
Collection 
Fresh frozen tissues are ideally suited for MALDI MSI studies[50]. It is important to 
minimize the time between harvesting the sample and its preservation to reduce sample 
degradation by endogenous enzymes. Commonly, a cryogen like liquid nitrogen allows 
snap freezing of the biological samples for stabilization. A snap-frozen tissue can be 
stored at temperatures below -70 °C for a minimum of one year without detrimental 
effects on the quality of MALDI MSI results[51]. Another possibility to preserve 
samples is fixation (e.g. formalin-fixed tissues), which is ubiquitously used for clinical 
studies and a huge amount of archived fixed samples already exists. However, it is not 
optimal for tissue preservation in MALDI imaging studies, because there is no control 
of molecules diffusion during fixation, in addition to the problematic mass 
spectrometric analysis of the cross-linked proteins[52]. Methods useful for the analysis 
of formalin-fixed samples have been described to leverage this vast source of 
information[53]. 
After biological samples are collected, they are cut through using a cryostat microtome 
into thin sections (3-20 µm) with the aim of obtaining a flat and even surface, for 
optimum imaging results[54]. It is required to optimize the cutting temperature and the 
tissue thickness individually for the different tissue types[50]. Sometimes it is required 
to embed fragile or small tissues in an embedding medium to support their sectioning. 
Classically, optimal cutting temperature compound (OCT) is the medium of choice for 
histopathological studies. However, it is not suitable for MALDI MSI since it ionizes 
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and causes up to 50% signal suppression due its high abundance[55]. Alternative 
embedding media like gelatin and carboxymethylcellulose (CMC) showed to interfere 
less with the analysis. Subsequently, tissues are mounted on the sample holder, which 
could be a glass slide, or a conductive surface in case of MALDI-TOF instruments (e.g. 
ITO glass slides), and stored at temperatures below -70 °C until analysis.  
Processing 
Before application of the matrix, optional processing of the samples can include some 
pretreatment steps. The processing protocol is tailored and validated according to the 
target analytes and could significantly improve the results of the analysis. This includes 
drying, washing, on-tissue digestion, and derivatization. 
After the removal of tissue sections from the freezer for analysis, they are dried to lessen 
instability by several methods, e.g. vacuum desiccation[56] or air under a stream of 
nitrogen[57]. Tissue washing should be carefully optimized because it directly affects 
composition and localization of the analytes within the sample. It is usually considered 
to remove ionization-suppressing small molecules and lipids during the analysis of 
proteins and peptides[58]. In some cases, on-tissue enzymatic digestion is needed to 
overcome the low sensitivity of the imaging analysis of intact proteins. This is 
particularly useful for formalin-fixed paraffin-embedded (FFPE) tissues, to liberate 
peptides from the cross-linked proteins[59]. Enzyme are either spray-coated in the same 
manner as the matrix, or applied using an automatic spotting instrument[60]. Also, 
different strategies for on-tissue chemical derivatization were introduced to imaging 
studies, to improve detection of low molecular weight drugs within tissues, where poor 
ionization efficiency, isobaric endogenous compounds, or ion suppression complicate 
the analysis[61]. Derivatization is relatively a new approach and of limited application 
due to variations in reactions yields and side reactions. 
Matrix selection and application 
Matrix application plays an important role in successful MALDI MSI analysis. Lateral 
resolution and detectability of the analytes are strongly decided by the choice of matrix 
and its method of application. Generally, the matrix coat applied to the sample surface 
should be very homogenous providing crystal structure size that matches the diameter 
of the laser beam to guarantee high quality ion images. The basic strategy is to apply 
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the matrix in a quickly evaporating solvent to extract the analyte, ensure proper 
crystallization, and minimize analyte diffusion[54]. 
Selection of matrix and solvent 
The matrix solution commonly includes three components, the matrix compound, the 
solvent, and triflouroacetic acid, which is added in many cases to promote ionization. 
The MALDI matrix is typically a low molecular weight organic acid with strong 
absorbance at the wavelength of the laser used. Many matrices proved useful for 
different compound classes[39, 54], however, the three most commonly used matrices 
for MALDI MSI are 2,5-dihydroxybenzoic acid (DHB), α-cyano-4-hydroxycinnamic 
acid (α-CHCA), and 3,5-dimethoxy-4-hydroxycinnamic acid (SA, sinapic acid)[59], as 
shown in Table 1. While SA is most suitable for the analysis of proteins, DHB and α-
CHCA are more suited for peptides, lipids and lower molecular weight analytes. 
Ideally, several matrices with different solvent composition should be experimented in 
both positive and negative ion modes to specify which matrix is the best for a certain 
analyte. The choice of solvent can cause significant differences in the properties of 
crystallization of matrices on the surface tissue sections[62]. Different combinations of 
water and organic solvents like, methanol, acetonitrile, acetone, and isopropanol are 
commonly used. A 50% organic solvent solution is a proper starting point for testing 
and optimization[55]. 
Other nontraditional matrices include ionic liquid matrices[63] (e.g. α-CHCA acid with 
2-amino-4-methyl-5-nitropyridine), inorganic metal matrices (e.g. gold 
nanoparticle[64], colloidal graphite[65]), in addition to matrix-free approaches[66]. 
These methods have their strengths and weaknesses, however, they are  less common 
due to limitations regarding sensitivity and applicability to a wide range of target 
compounds[59]. 
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Compound Structure Application 
DHB 
(2,5-
Dihydroxybenzoic 
acid) 
 
Peptides 
Lipids 
Oligonucleotides 
Carbohydrates 
α-CHCA 
(α-Cyano-4-
hydroxycinnamic 
acid) 
 
Peptides 
Pharmaceuticals 
Lipids 
Oligonucleotides 
 
Sinapic acid, SA 
(3,5-Dimethoxy-4-
hydroxycinnamic 
acid) 
 
Proteins 
Peptides 
Methods of matrix application 
Matrix coating can be either discrete, which is more common to profiling applications, 
or continuous. Discrete matrix application has the advantage of limited analyte 
diffusion and is usually performed using automated piezoelectric spotters dispensing 
picoliter volumes of the matrix solution[54]. Continuous matrix application is the mode 
used for MALDI imaging. 
It can be performed by a number of methods like, spray-coating, electrospray 
deposition, or solvent-free dry matrix application (e.g. sublimation, sieving)[68]. 
Table 1. Chemical name, structures, and application of common matrices used in MSI 
analysis[67]. 
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Manual spray-coating using a pneumatic airbrush sprayer is cost-effective, 
nevertheless, it is difficult to standardize across multiple samples and laboratories 
because it is subjective and depends on the skills of the analyst. Automatic spraying of 
the matrix is the method of choice for the majority of MALDI MSI community because 
it overcomes the lack of reproducibility associated with manual spraying. A number of 
commercially available robotic sprayers having almost the same working principle is 
available on the market[59]. The matrix solution is sprayed as fine aerosol and allowed 
to deposit on the tissue surface. The coat is allowed to dry and several iterations are 
normally needed to obtain enough amount of matrix for the analysis. 
Other less common methods for matrix application in MALDI MSI include 
sublimation, which produces uniform very small matrix crystals making it suitable for 
high resolution imaging[59]. Also, the use of commercial desktop inkjet printers 
provided a low-cost method utilizing the same principle of automated chemical 
spotters[69]. Automatic spotters cover the samples surface with a spaced array of small 
matrix droplets (picoliter volumes) providing both automated uniform matrix coating 
and sufficient permeation into the tissue[68]. 
Lasers 
MALDI MSI studies reported the use of ultraviolet (UV) and infrared (IR) lasers. UV-
MALDI is the most widely used mode. It commonly utilizes nitrogen (N2) gas lasers 
because they are simple, small-sized, and relatively low in cost. Their emission 
wavelength (λ = 337 nm) is close to the absorption maximum of many commonly used 
matrices such as DHB, α-CHCA, and SA. Disadvantages of N2 lasers include limited 
pulse repetition frequency (< 100 Hz). Also, their relatively short lifetime (total number 
of emissions ≤108 which normally correlates to ≤2 years) limits their application in 
high-throughput analysis[70]. For such type of applications, frequency-tripled Nd:YAG 
solid state lasers (λ = 355 nm) having longer time spans are used. The Nd:YAG lasers 
also provide more sensitive MALDI MSI analysis due to achievable repetition rates of 
up to 1000 Hz[71]. 
IR-MALDI is relatively less common. It utilizes liquid matrices providing better 
spectral reproducibility in comparison to UV-MALDI, which mostly uses solid state 
matrices with relatively high degree of heterogeneity depending on analyte-matrix co-
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crystallization[72]. Examples for IR lasers employed in MALDI MSI studies include 
pulsed erbium solid-state lasers (Er:YAG, λ = 2.94 µm and Er:YSGG, λ = 2.79 µm). 
Desorption and ionization 
The desorption and ionization processes in MALDI are extremely complex involving a 
large number of intertwined physical and chemical events and have been the focus of 
many research groups[73, 74]. A comprehensive discussion of these events is beyond 
the scope of the thesis. Hence, only a brief overview follows in the next paragraphs. 
Desorption 
Desorption of the matrix and analyte occurs when a sufficient energy density is 
achieved through short pulse durations (ns) of the laser. Energy deposition is affected 
by a number of parameters including sample properties, matrix absorption, sample 
surface characteristics, and most importantly, the laser fluence (J cm-2) [74]. Generally, 
a rapid phase transition of the bulk matrix-analyte material from solid to gas occurs 
leading to disintegration of the top layers. The disintegration event may be 
characterized as ‘‘desorption’’ or ‘‘ablation,’’ depending on the laser fluence. In the 
desorption regime, the solid to gas transition is smooth at the top surface of the sample, 
and the emitted material contains little or no condensed particles, droplets or clusters. 
At higher ablative fluences, the sample is sufficiently overheated that subsurface 
nucleation occurs, leading to ‘‘phase explosion’’ which is turbulent and frothy. This 
ejects condensed material consisting of particles and clusters. According to literature, 
MALDI is often performed in the ablation regime[68, 73, 75, 76]. 
Ionization 
Much research has focused on the specific mechanisms of the MALDI ionization 
processes and numerous theories and models have been proposed. A consensus that 
supports the idea of several processes occurring and not just one single event, has been 
reached. 
These competing processes are evidenced by the presence of a variety of ionized species 
in the mass spectrum that may be protonated, deprotonated, cationized, or radicals[77-
82]. It is generally accepted that ion formation follows a two-step model. Primary 
ionization is the first step, it refers to ions produced from the neutral molecules of the 
Introduction 
15 
 
sample surface and it mostly involves a contribution of the matrix. Ion-molecule 
reactions in the desorption/ablation plume follow, giving rise to secondary ions which 
reach the detector (secondary ionization)[83]. 
Whereas, various models for generation of primary ions are still somewhat divergent, 
mechanisms for secondary ionization have been widely accepted, as they are believed 
to follow basic condensed phase ‘plume’ kinetic and thermodynamic rules. Several 
mechanisms and models were proposed to explain the primary ionization, among which 
“the cluster ionization mechanism” also known as “the lucky survivor model”[77-79], 
and “the photoexcitation/ pooling mechanism” known as “the coupled physical and 
chemical dynamics model” (CPCD)[80-82] are the most widely accepted. The key 
points for both models are briefly discussed. 
Primary ionizaion 
The lucky survivor model  
Also known as “the cluster ionization mechanism”, this model proposes that the analyte 
ions are largely preformed in the solid matrix and considers matrix mainly as an 
ablation vehicle and does not contribute preformed ions. The evidence for the 
preformed ions in the solid matrix was observed during the preparation of MALDI 
samples of pH sensor dyes from solutions of different pH[84]. The solid samples 
retained the color of the original solution, indicating that the dye molecules had the 
same ionized state as in solution. 
The disintegration of the solid matrix upon laser irradiation leads to the formation 
aggregates having an excess of positive or negative charge. Once in the expanding 
plume, the charged clusters dissociate and undergo extensive but incomplete 
neutralization in the plume by counterions leaving some ions at the end. The 
neutralization happens by losing neutral matrix molecules to release the analyte ions or 
by ejection of the ions. 
For this reason, the model is called “the lucky survivors”[78], indicating that they are 
the ones which survived the neutralization process, and justifying the presence of the 
singly charged species. 
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The Coupled Physical and Chemical Dynamics model (CPCD)  
This model is also known as ‘’the photoexcitation/ pooling mechanism”, and on the 
contrary to the cluster model, almost all primary ions are derived from the matrix. It is 
based on the initial photoexcitation of the matrix with consequent migration of the 
excitation energy within the matrix crystals. This is followed by the concentration of 
this energy by two sequential pooling events resulting eventually in ionization[85]. The 
combination of migration and pooling events is necessary because direct 
photoionization by two- or multi-photon absorption of matrix or matrix-analyte 
complexes, is less likely. This is because the ionization potentials (IP) of nearly all 
MALDI matrices lie above the 2-photon energy of the typical UV-MALDI lasers, even 
in condensed clusters where the IP is expected to drop[81]. However, this amount of 
energy can be concentrated on one molecule by two sequential pooling events. The 
model assumes that the excitation energy (known as excitons[86]) is mobile in the 
crystals with stacked aromatic π-electron systems of matrices. Pooling happens through 
redistribution of excitation energy of two neighboring molecules resulting eventually 
in de-excitation of one of the two molecules to the ground state and ionization of the 
other one. The excited states interact either in S1-S1 or S1-Sn pooling, the latter being 
responsible for ionization[83]. 
Secondary ionization 
Secondary ionization starts as soon as primary ions exist, hence it could occur 
concurrently to primary ionization when the material is still dense allowing extensive 
ion-molecule reactions.  It includes charge transfer between matrix and analyte and 
between analytes, and it occurs in the expanding plume and takes much longer in 
comparison to primary ionization. Changes in the density allow the collisions and 
interactions of the primary ions with the neutral molecules to give new ions[67, 81].  
The charge transfer is assumed to be reversible and could occur through the following 
main reactions: 
- Proton transfer: mH+ + A ↔  m + AH+ , and (m-H)- + A → m + (A-H)- 
- Electron transfer: m+ + A ↔ m + A+ , and m- + A → m + A- 
- Cation transfer: e.g. mNa+ + A ↔ m + ANa+ 
Where, m = matrix, A = analyte. 
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Mass analysis 
After desorption and ionization, the analytes enter the mass spectrometer where they 
are separated based on their mass-to-charge ratio (m/z). MALDI ion source has been 
coupled to a variety of mass spectrometers for imaging applications including, time-of-
flight (TOF), quadrupole ion trap, Fourier transform-Orbitrap, and Fourier transform-
ion cyclotron resonance (FT-ICR) mass spectrometers. 
The versatility of the of the MALDI ion source for MSI applications allowed many 
companies and research groups to focus on instrument and software developments, 
which resulted in the availability of several MALDI mass spectrometers with variable 
MSI capabilities on the market. The specific MSI application determines the choice of 
the instrument, for example, the requirements necessary for protein imaging differ 
largely when compared to small molecules. The important qualities that determine the 
choice of a MALDI MSI instrument include spatial resolution, mass range, mass 
resolving power, mass accuracy, sensitivity, tandem MS capabilities, throughput, and 
data storage[50, 59]. 
Classically, MALDI ion source has been coupled to TOF mass analyzers, this was 
largely due to the nature of the ion source, producing pulsed ion packets, which were 
suitably measured and analyzed using a TOF analyzer. In TOF mass analyzers, ions are 
accelerated to a very narrow range of kinetic energies, then separated according to their 
m/z in a flight tube. Although MALDI-TOF instruments offer excellent throughput, 
they suffer limited mass resolving power and mass accuracy essential for direct mass 
identification of analytes in biomolecular imaging studies. MALDI-FT-ICR and 
MALDI-FT-Orbitrap are on the other hand high performance alternatives, which offer 
high mass resolving power and high mass accuracy. 
These methods have shown to resolve and identify ions at a single nominal mass that 
are commonly present in MALDI imaging mass spectra[87]. 
This work includes imaging measurements that has been mainly done using a hybrid 
linear quadrupole ion trap-Orbitrap instrument; MALDI LTQ Orbitrap XLTM (Thermo 
Scientific). The instrument can operate as a standalone version of either the linear 
quadrupole ion trap or the orbitrap, or as a hybrid device of both. The working principle 
of the linear ion trap and the orbitrap follows in the next paragraphs. 
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Linear quadrupole ion trap 
The geometry of the linear ion trap could be seen in Figure 4. It consists of four 
electrode rods cut into three axial segments. The central section where ions are stored is 
longer in comparison to front and back sections, which are of equal but shorter length. 
A combination of radiofrequency (RF) and direct current (DC) voltages are applied to 
opposite pairs of rods to trap the ions. The linear ion trap is versatile and can operate to 
store, isolate, dissociate the ions and then send them to the Orbitrap for further analysis 
(axial ion ejection). Alternatively, it can also operate as an independent mass analyzer 
sending the ions directly to the detector (radial ion ejection to the electron multiplier 
detector). It is a low resolution device that when combined to other mass analyzers 
offers improved space-charge capacity, increased sensitivity due to higher ion storage 
capacity, and more efficient ion injection[67]. 
Orbitrap 
The Orbitrap consists of a central spindle-shaped electrode surrounded by a pair of bell-
shaped outer electrodes, together they form a barrel-like shape ( Figure 5). It employs 
an electric field to trap the ions orbitally. The orbital motion of the ion is related to the 
ion kinetic energy and is used for radial trapping and not for mass analysis. In the axial 
direction, ions oscillate harmonically from one end of the barrel assembly to the other 
while they continue to orbit around the central spindle electrode. The frequency of the 
back-and-forth axial oscillations determines the m/z ratio[89]. Two split halves of the 
outer electrode of the Orbitrap detect the image current produced by the oscillating ions. 
 
Figure 4. Basic design of the two-dimensional linear ion trap (adapted from Schwartz 
et al.[88]) 
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By Fast Fourier Transformation (FFT) of the image current, the instrument obtains the 
frequencies of these axial oscillations and therefore the mass-to-charge ratios of the 
ions. Orbitrap is a high performance device that allows direct and accurate identification 
of biomolecules due to high mass resolving power [89]. 
 
Figure 5. Orbitrap mass spectrometer. Curved arrows show the stable ion trajectories. 
R1 and R2 represent the electrodes radii (adapted from Makarov et al.[90]) 
MSI software 
One of the principal goals of data analysis in MSI experiments is to determine trends in 
the spatial distributions of biomolecules, which can be related back to the underlying 
biology. MALDI MSI data sets can be many tens to hundreds of gigabytes depending 
on the specimen size, image resolution, and spectral resolution. This developed the need 
for software programs to process the highly complex MSI datasets. Generally, MSI 
software tools can be classified into two main categories which control either data 
acquisition or processing (visualization and analysis in order to generate ion images). 
Data acquisition software 
This type of software is designed to register the target location or region of interest 
defined by the user. It defines the target location by allowing the user to draw a shape 
around the area of interest using an optical image of the sample, and setting the spatial 
resolution within this area. Afterwards, automated acquisition is initiated to collect 
mass spectra at each position in the raster pattern. Image acquisition software could be 
separate or integrated in the standard instrument control software[59]. 
Image analysis software 
After image acquisition, proper data processing and analysis of datasets is crucial for 
accurate interpretation of the results. The MSI dataset has a specific data format that 
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depends on the measuring instrument. Most mass spectrometers have a proprietary data 
format, which can be exported to the image processing software provided by the vendor 
such as, FlexImaging (Bruker), Tissue-View (ABSciex), and ImageQuest (Thermo).  
On the other hand, a number of open source software for visualization and processing 
of MSI data has been described. For example, MSiReader, an open source program to 
view and perform data analysis of MSI data has been described[91]. It has been rapidly 
taken up by users and provides a Matlab interface allowing it to be adapted to individual 
needs. Also, OpenMSI, a Web-based open source software, provides a high-throughput 
solution for image data processing. Large imaging data sets can be stored and processed 
on a central high performance server, while users visualize the resulting images on local 
computers[92].  
In this respect, common data formats have proven to be useful allowing data exchange 
between different instrumental platforms and between different image evaluation and 
processing software tools. Two of the most common open-source formats for MSI data 
are Analyze 7.5 and imzML[59]. Data analysis of MSI measurements in this work has 
mainly used the common data format imzML. 
imzML. The initiative for developing imzML was to ensure flexible and fast handling 
of the MSI data, provide complete description of the MSI experiment, and minimize 
the data file size. It was developed to follow the standards proposed by the Human 
Proteome Organization- Proteomics Standards Initiative for storing mass spectrometry 
data. It is consistent with the existing mzML format and consists of two separate files. 
The binary file (*.ibd) stores spectral data, and the (*.imzML) file stores all associated 
metadata. Both file types are required to fully describe the dataset[93, 94]. 
The imzML format has been adopted by a growing number of instrument vendors and 
continues to be used by developers of open-source MSI image processing software. 
MSI data processing 
Spectral preprocessing 
The data analysis process can be generally divided into two separate processes, data 
preprocessing, and analysis. MALDI MSI data show experimental variance within the 
raw dataset. For this reason, preprocessing of the data is useful to reduce such variance 
before the analysis of the data in order to obtain confident conclusions and improve 
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subsequent processing. Spectral preprocessing could involve baseline correction 
(denoising or removal of background), realignment, normalization of intensity, and 
peak picking. 
Baseline correction 
The intensity value recorded for each element in the profile spectrum is commonly 
associated with a certain amount of noise or background. The amount of noise is 
instrument-dependent and arises from experimental fluctuations. Possible sources may 
arise from transient detector gain variations or statistical fluctuations in ion motions. A 
number of algorithms have been reported for estimating background and many 
commercial data analysis software packages include baseline correction modules[95]. 
It is worth to mention that baseline artifact is much reduced from mass analyzers that 
include an orthogonal mass separation stage, such as hybrid instruments[96]. 
Normalization 
In general, it is important to normalize ion intensities to minimize differences in peak 
intensity between spectra, i.e. scaling each spectrum to some factor for better 
intercomparison of intensities between different spectra[97]. 
These differences in intensity values could arise from variation in instrument 
performance, as well as differences in sample preparation, inherent sample variability, 
and experimental error. Normalization has been routinely applied in many areas of mass 
spectrometry, especially for quantitative analysis where ion intensity is normalized 
against the intensity of an internal standard that has similar ionization characteristics as 
the analytes of interest. 
For MALDI MSI, several normalization methods have been described to address the 
variability in signal intensity[69, 95, 98-105]. This includes the often used 
normalization to Total Ion Current (TIC). It is recommended that visual examination of 
exemplary m/z-images after TIC normalization should be considered[97], since for 
some MSI software, TIC normalization makes the assumption that the same number of 
ions will be produced from each spatial location[100, 106], which could introduce 
artifacts and limits the reliability of the method[95, 98]. Also, normalization to matrix 
related peaks[99] was used for correction of uneven matrix thickness and 
crystallization. However, this method assumes that endogenous biomolecules respond 
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evenly to changing matrix conditions, limiting the success of this approach as well[3]. 
Other methods implement normalization algorithms based on noise levels, and median 
signal intensity of the spectrum[98, 100]. On the other hand, the most promising 
approaches for MSI signal normalization seem to be those applying internal standards, 
enabling pixel-by-pixel correction of raw intensities[42]. 
Calibration and realignment 
Systematic shifts that affect the whole spectrum (e.g. due to instrument fluctuations) 
can be compensated for with recalibration or online lock mass calibration using known 
ions within each spectra (e.g. matrix peaks)[107]. However, variability in the centroid 
m/z detected for an individual peak (mass shifts within the mass accuracy range) 
throughout the course of a number of replicate measurements (or between the different 
spectra) can cause problems for quantitative comparisons, even with a properly 
calibrated instrument. 
Moreover, irregularities within the flatness or thickness of tissue sections boost this 
mass measurement variability. In such case, calibrating each spectrum to known peaks 
that are common to the dataset and can be recognized within the spectra (i.e. internal 
calibrants or landmarks), can effectively realign the spectra to ensure that comparison 
considers the intensity of the same ions across a number of samples. It is also important 
that these common peaks span the entire mass range of interest to prevent extrapolation 
outside of the chosen alignment points[95]. 
Peak picking 
Peak picking is the selection of m/z values which correspond to high and relevant peaks 
with the aim to reduce the number of m/z values by neglecting those values 
corresponding to noise signals or to non-specific baseline signals[97]. Various peak 
picking methods for MALDI mass spectra are implemented in mass spectrometry 
imaging software packages. Nevertheless, this process has showed to be difficult to 
perform in a blind automated manner due to the presence of unresolved peaks. Hence, 
it is recommended to carefully visualize the results in order to validate the labeled peaks 
manually[59]. 
Introduction 
23 
 
Data analysis 
A list of m/z values and their corresponding intensity or peak areas extracted from each 
spectrum in the data set, is usually the output of the preprocessing steps previously 
described. Depending on the biological task under investigation, this data can be subject 
to a number of data-mining methods with the aim of information extraction. 
A simple approach is to use the resulting list of m/z values to identify specific molecules 
of interest in the dataset. Then, the localization of the specific molecules (drugs, 
metabolites, etc.) is compared in disease-state tissue with physiological one to search 
for disease biomarkers. In this approach, it is beneficial to examine the resulting ion 
images and the histological staining images of both tissues types to link distinct 
molecular distributions to histological features[6]. 
Other data mining approaches include a set of statistical methods that allow spectral 
classification of the data and results in a collection of ion images and/or spectra, which 
show important features within the dataset. 
A well-known example is principal component analysis (PCA). It is an unsupervised 
method that groups together peaks whose intensities are correlated in certain areas of 
the tissue. The output of the analysis is a set of principle components that are rank-
ordered according to the amount of variance that they describe in the data. 
Software developers have developed MSI software packages to facilitate the analysis 
of MSI data. Commercial software packages, such as Multimaging (Imabiotech, 
France) or SCiLS (Bruker Daltonics, Germany) can handle large-sized, multi-sample 
data sets and include many statistical tools for biomarker discovery[108]. Open-source 
software is available as well, such as MSiReader[91] or Biomap[109], but is less 
focused on the simultaneous analysis of several samples. Also, studies reported 
different in-house developed data mining approaches for MALDI MSI datasets[110, 
111]. 
Biological applications of MALDI MSI 
MALDI is currently a dominant technique in biomolecular MSI, owing to its versatility 
and its widespread commercial availability[7]. Several biomolecule classes including 
proteins, peptides, lipids, drugs, and carbohydrates have been investigated in diverse 
biological tissues[39]. 
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In the following, a number of examples with a focus on MSI of lipids, will shed light 
on some areas where MALDI MSI studies of different molecule classes contributed to 
the understanding of biological processes. 
MALDI profiling studies of proteins were reported in various cancer tissues showing 
protein content specific to each tumor type such as those of the brain[112] or lung[113]. 
Also, proteomic changes detected by MALDI profiling studies in mouse tumors, proved 
useful to correlate the variation in protein profiles to the disease progression, which is 
important for evaluation of treatment efficiency and prognosis. For neurodegenerative 
diseases, brain distribution of proteins led to the identification of a biomarker protein 
of Parkinson’s disease in a mouse model[114]. Also, molecular physiology of the eye 
was the subject of MALDI MSI studies, which reported the modifications and 
distributions of crystalline proteins in the lens and correlated this to clinical conditions 
like formation of cataracts[115]. 
Peptides were also attractive targets for MALDI MSI investigations because their peaks 
are generally more intense and resolved than proteins[89]. The specific distribution of 
amyloid peptides in brain tissue of a mouse model of Alzheimer’s disease was 
investigated[116]. Also, investigations of various neuropeptides were the focus of a 
number of MALDI MSI studies[117-119].  
Application of MALDI to the imaging of pharmaceutical compounds has been of great 
interest to study the distribution of drugs in tissue specimens. Examples include the 
imaging of MRI contrast agents in fresh and fixed tissues. The distribution of the 
contrast agent, a Gd-containing compound, was further validated with MRI and 
inductively coupled plasma atomic emission spectroscopy[120]. Also, the controlled 
release of drugs and their distribution into the adjacent tissue by implanted medical 
devices (drug eluting coronary stents) was studied by MALDI MSI[121]. The 
distribution of tiotropium, a bronchodilator for the management of chronic obstructive 
pulmonary disease, that is administered via inhaled delivery, was imaged in lung tissue 
to better understand the distribution in lung tissue of rats[102]. 
MALDI MSI of lipids 
Many applications of MALDI MSI focus on lipid analysis because of their diverse roles 
as structural components of cell membranes, their function in the surfactant cycle, and 
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their involvement as second messengers in signaling cascades of tissues and cells[68]. 
A few examples are presented in this section. 
Alterations in lipid distribution due to changes of physiological or pathological 
conditions could be detected in rodent brains by MALDI MS. For example, age-related 
changes in the distribution and amount of phosphatidylcholine (PC) species in rat brain 
have been investigated[122]. Also, a study of rat brain demonstrated the localization 
changes of brain lipids after traumatic brain injury[123]. In a different study, 
investigation of PC and sphingomyelin (SM) species could distinguish brain 
compartments[124]. Furthermore, cholesterol localization showed lower abundance in 
the cell nuclei of the granular layer as compared to white matter structures in a study of 
rodent cerebellum[125]. Profiling of phospholipids and lysophospholipids in rat brain 
of experimentally infarcted rats, showed a conversion of phosphatidylcholine to 
lysophosphatidylcholine, suggesting a role of lysophosphatidylcholine in the 
progression of brain injury during ischemic stroke[126]. 
Other lipid studies of MALDI MSI included other tissues of mice as well. Visualization 
and identification of phospholipids in the mouse retina by MALDI MSI showed a three-
zone distribution of PC species[127]. A mouse model of glycosphingolipid storage 
disease was used to study the changes of sulfatide lipids in kidney tissue[128]. 
Visualization of different lipids species (SM, lyso-PC, PC) in mouse tongue was also 
reported[129].  
In addition, tissue sections from different human organs were studied by MALDI MSI 
for numerous purposes. A few examples include a study of the distribution of lipids in 
human brain cortex, which allowed to distinguish grey and white matter 
effectively[130]. Also, the role and distribution of lipids in tumor tissue has gained 
growing attention, although, applications of MALDI MSI to cancer research has mostly 
focused on proteins and peptides. Lipid changes observed in myxoid liposarcomas 
could be related to pathways known to be affected during tumor progression which 
helped identify tumor type and grade[131]. A study of ovarian cancers showed 
differential distribution and higher levels of sulfatides[132]. A different study of human 
lenses reported on the age-related profiles of lipids, showing an accumulation of 
dihydroxysphingomyelin, DHSM (d18:0/16:0) and dihydroxyceramide, DHCer 
(d18:0/16:0) in the barrier and nucleus regions, respectively[133]. 
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3D MALDI 
Constructing a 3D view of the distribution of biomolecules in the tissue has gained 
growing interest in MSI techniques. MALDI MSI is basically 2D imaging method, 
however, obtaining a 3D view is possible by analyzing serial sections of the sample and 
merging the individual 2D images into one 3D representation using a special software, 
such as, Image J[3, 108]. Care should be taken that the distance between the analyzed 
serial sections is appropriate for the tissue structure to be reconstructed, and also to 
process the sections under identical conditions[6]. The details of serial sectioning 
approach to create 3D MALDI images of different biomolecules was described for a 
variety of different samples[134-136]. This includes 3D imaging of protein and peptide 
distribution in rat midbrain[137], and a reconstructed 3D view of mouse brain using 
myelin basic protein[138]. 
A recent study presented a different approach using an autofocusing AP MALDI MSI 
system for studying 3D sample surfaces with topographic aspect. The developed system 
keeps the MALDI laser focus, fluence and ablation spot size constant over sample 
height variations by adjusting the sample stage position according to the sample height 
profile for each measurement spot[139]. 
1.2.4 Laser Ablation Inductively Coupled Plasma - LA-ICP 
LA-ICP-MS allows the distribution analysis of metals on the surfaces of tissue sections 
without pretreatment, such as matrix application. A focused laser beam is used to ablate 
sample material which is transported by a carrier gas (Ar or He) into the ICP source. In 
the ICP operated at 7000−8000 K, the sample material is atomized and ionized, and its 
elemental components are analyzed[140, 141]. It is the method of choice for the 
imaging of elements in thin cross sections of biological tissues and is currently 
considered as the most sensitive technique for elemental bioimaging[142]. Spatial 
resolution range of 4 to 100 µm and limits of detection in the range of 0.001 – 1 µg g-
1, could be achieved. The merits of LA-ICP-MS are high throughput, high sensitivity, 
and high accuracy. In addition, minor matrix effects allow quantification of the 
analytical data[140]. 
The numerous applications of LA-ICP-MS as a bioimaging tool include the 
investigation of Parkinson´s disease, stroke and aging in brain tissues, metal uptake, 
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cancer studies, etc. In addition, LA-ICP-MSI was used to scan 1D and 2D gels and 
blotting membranes to analyze metals in protein bands or protein spots[140-142]. 
1.3 Multimodal imaging 
Combining information obtained from different MSI methods and other imaging 
techniques allows to explore additional information, such as structural information 
classically obtained from histological staining or Magnetic Resonance Imaging (MRI) 
and molecular information from MSI. Figure 6 illustrates a number of possibilities to 
combine data from various imaging techniques to MSI results. Such combination 
approaches are very powerful and increase the conclusiveness, validity, and informative 
value of MSI data[38]. 
 
Figure 6. Combining of MSI data and different imaging techniques (adapted from 
Bodzon-Kulakowska et al. [6]). 
A classical approach of combining data from MS-based approaches to other analytical 
methods is to correlate the molecular data to structural information obtained from 
histological staining like H&E. This requires coregistration of the resulting ion images 
and microscopic images of H&E staining. For this, a tissue section consequent to that 
measured by MSI could be used for staining. For unambiguous correlation between the 
data, the histological staining could be performed on the same tissue section measured 
by MSI. In case of MALDI imaging, this requires matrix removal by rinsing the tissue 
section briefly with ethanol, or ethanol and acetone[137]. 
Combining results from different MSI approaches is also considered as beneficial since 
they differ in their analytical capabilities. An example was presented in a study where 
the same tissue section was first analyzed by DESI for lipid profile using a 
‘‘morphologically friendly’’ solvent system which does not destroy the sample (e.g. a 
combination of DMF with different solvents). MALDI analysis followed to obtain 
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information about the peptide constituents. Finally, the tissue could be stained with 
H&E for structural features[45]. 
Another example presented a combination of MALDI and SIMS imaging to study the 
distribution of electrolytes, lipids and peptides in a mouse model of rheumatoid 
arthritis. The localization of different lipids and tryptic peptides was revealed by 
MALDI, whereas SIMS measurements indicated the localization of potassium, 
calcium, cholesterol and several other lipids in various areas of the knee joint[143]. 
Moreover, combination of the quantitative elemental mapping by LA-ICP-MS and the 
molecular imaging of lipids by MALDI allowed correlate different sets of analytes from 
the same sample and develop comprehensive data analysis[140]. 
In a different study, an interesting approach developed a coregistration technique using 
fiducial markers (cresyl violet, Ponceau S, and bromophenol blue), which possess a 
combination of optical and molecular properties. This allowed accurate coregistration 
of fluorescent protein expression images with MSI images and reconstruction of 3D 
images of molecules distribution from a breast tumor model[134]. 
Another approach of multimodal imaging involved combining MS-based imaging 
methods to MRI. MRI enables to view the 3D anatomic structure of an organ of interest 
with significant resolution. Combining molecular results from MSI with detailed 
anatomical information from MRI was reported in a number of studies. Combining MRI 
and MALDI data showed altered abundance of different proteins in an imaging study 
of the inflammatory response to S. aureus infection in mice[135]. An important 
application of merging results from MRI and MS-based imaging modalities was 
reported for neurosurgery, where accurate removal of tumor tissue without affecting 
healthy tissue is necessary. The MRI image, recorded before the surgery in combination 
with a special cranial navigation tool (www.brainlab.com) and a special stereotactic 
neuronavigation pointer were used to precisely indicate the place from which the tissue 
is collected. This was followed by DESI analysis of obtained tissue sections, which 
enabled the classification of tumor subtype, grade, and cancerous cell 
concentration[144].  
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1.4 Lipids and lipidomics 
1.4.1 Lipids 
Lipids have essential roles in living cells including being main constituents of cellular 
membranes (membrane lipids), acting as precursors for lipid second messengers during 
signal transduction (bioactive lipids), facilitating transmembrane protein functions, in 
addition to providing fuel supplements for many biological processes (energy lipids). 
Also, more evidence nowadays shows that lipids are associated with many human 
diseases (e.g. diabetes, obesity, atheroscelerosis, stroke, cancer, psychiatric disorders, 
neurodegenerative diseases, and infectious diseases)[145]. Therefore, the research on 
lipids has gained a lot of attention and became an emerging field of basic and 
translational research. 
The majority of lipid molecules could be defined as amphiphilic molecules composed 
of a hydrophobic and a hydrophilic components. They originate entirely or in part by 
carbanion-based condensations of ketoacyl thioesters and/or by carbocation-based 
condensations of isoprene units. Fatty acyls, glycerolipids, glycerophospholipids, and 
sphingolipids are derived by carbanion-based condensations, while sterols and prenol 
lipids originate from carbocation-based condensations[146, 147]. 
Chemists have classified lipids in a number of different ways. A simple classification 
distinguishes lipids simply into polar and nonpolar based on the overall hydrophobicity 
of the lipids. Nonpolar lipids are soluble in nonpolar solvents such as hexane, ethers 
and esters and include fatty acids and their derivatives (long chain alcohols and waxes), 
glycerol-derived lipids (mono-, di- and tri-acylglycerols), and steroids. Polar lipids are 
soluble in relatively polar solvents such as alcohols and include lipids containing polar 
head group such as glycerophospholipids. Biochemists classified lipids according to 
their function into membrane lipids, bioactive lipids, and energy lipids as mentioned 
earlier. 
The widely accepted classification of the LIPID MAPS consortium divides lipids into 
eight main categories: fatty acyls, glycerolipids, glycerophospholipids, sphingolipids, 
saccharolipids, and polyketides (derived from condensation of ketoacyl subunits); 
sterol lipids and prenol lipids (derived from condensation of isoprene subunits)[147]. 
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The work in this dissertation focuses on the lipid category known as 
glycerophospholipids (GPLs). 
Glycerophospholipids (GPLs) 
GLPs are principal components of cellular membranes. They are involved in numerous 
physiological processes, including membrane trafficking and cell signaling. 
Polyunsaturated fatty acids (PUFAs) are hydrolyzed from membrane GPLs and are 
further metabolized into numerous biologically active molecule[145]. 
The backbone of GPLs is a glycerol molecule substituted at the sn-3 carbon by a 
phosphate functional group, known as the polar head group, which defines the subgroup 
or class of the lipid (Figure 7). The main head group classes are phosphatidylcholine, 
phosphatidylethanolamines, phosphatidylserines, phosphatidylinositols, 
phosphatidylglycerol, and phosphatidic acid. The glycerol backbone is esterified with 
long-chain fatty acids (FAs), at the sn-1 and sn-2 positions[145, 148]. 
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Figure 7. Structure of glycerophospholipids (GPLs). GPLs consist of a glycerol 
backbone, a polar head group, and two fatty acid tails (R1 and R2). 
1.4.2 Lipidomics 
The biological system can be broken down to essentially four basic components, (i) 
genome, (ii) transcriptome, (iii) proteome, and (iv) metabolome which includes the 
lipidome (Figure 8). The degree of complexity increases from the genome (made up of 
essentially four nucleotides) and transcriptome, to the proteome (made up of 20 amino 
acids), to the metabolome (shows variability at the atomic level and includes 
nucleotides, amino acids and small peptides, sugars, and lipids)[148]. The lipidome 
could be defined as the entire collection of chemically distinct lipid species in a cell, an 
organ, or a biological system. 
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Hence, lipidomics could be referred to as an analytical chemistry-based research field 
styding lipidomes in a large scale and at the levels of intact molecular species, in 
analogy to other “-omics” disciplines[145]. Research in lipidomics has largely focused 
on the following areas: 
• Identification of novel lipid classes and molecular species. 
• Development of quantitative methods for the analysis of lipids in different 
biological systems. 
• Network analysis to clarify metabolic adaptation in health and disease tissue. 
• Biomarker analysis to facilitate diagnosis of disease states. 
• Tissue mapping of altered lipids present in complex organs. 
• Bioinformatics approaches for the automated high-throughput processing and 
molecular modeling of lipidomics data. 
Many analytical methods have been developed for the analysis of lipids, including thin-
layer chromatography (TLC)[149], gas chromatography(GC)[150], liquid 
chromatography (LC), enzyme-linked immunosorbent assays (ELISA)[151], nuclear 
magnetic resonance (NMR)[152], and mass spectrometry (MS)[153]. Among them, 
MS-based methods achieve the highest sensitivity and specificity, throughput, and 
 
Figure 8. Schematic representation of the interrelation between the genome, 
transcriptome, proteome, metabolome, and lipidome. (adapted from Griffiths et al. 
[148]) 
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accuracy[154]. The following section presents an overview of popular MS-based 
methods for lipid analysis.  
Mass spectrometry-based lipidomics approaches 
MS-based techniques can be different in their analytical spectrum (e.g., ‘targeted 
analysis’ vs. ‘global analysis’). They also differ with respect to the absence or presence 
of extraction protocols and/or liquid chromatography (LC) prior to the mass 
spectrometric analysis[155]. In principle, lipids can be analyzed directly from the 
biological materials (tissue section or cell samples) by MS imaging[156]. Alternatively, 
biological samples are extracted with organic solvents and lipid solutions are analyzed 
either by shotgun lipidomics[157] or by chromatography-based lipidomics, particularly 
LC-based lipidomics[158]. 
Biological lipid extracts are typically complex, including the diversity in lipid 
classes/subclasses/molecular species and the vast dynamic range in the endogenous 
contents of individual species. Therefore, reduction of the complexity of lipid extracts 
is essential for reliable and accurate identification and quantification of individual 
species in the complex extract. This is particularly important for shotgun approaches 
because they apply no chromatography for separation or enrichment prior to MS 
analysis, unlike LC-based lipidomics which achieves this utilizing separation science 
in addition to enriching the low abundance species[153]. 
Shotgun lipidomics is a direct infusion-based approach that analyzes lipids without pre-
chromatographic separation prior to mass spectrometry. Electrospray ionization (ESI) 
and matrix-assisted laser desorption ionization (MALDI) are the most widely used ion 
sources in direct infusion MS analysis. 
A unique feature of shotgun lipidomics is the high-throughput analysis of lipids under 
constant concentration conditions. Particularly during direct infusion ESI-MS analysis, 
this feature provides many advantages for quantitative applications. Constant 
interactions between the lipid species are maintained which results in constant ion 
suppression between the different species and hence constant contribution of an 
individual lipid species to the ion current in an ESI source[145]. This also allows 
virtually unlimited time to improve signal/noise ratio and to perform detailed MS/MS 
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mapping under constant composition of solvents and analytes, in contrary to time 
constraints present during chromatographic elution[155].  
In the practice of shotgun lipidomics, the sample complexity could be reduced either 
during sample preparation or during MS analysis. Reducing complexity during sample 
preparation can be done through physical approaches (e.g., liquid/liquid partitioning or 
solid phase extraction to separate polar vs. nonpolar lipids)[159] or chemical 
approaches (e.g., base hydrolysis to enrich low abundance sphingolipids from complex 
lipid extracts containing high abundance phospholipids and/or glycerolipids)[160]. 
Another possibility is to use derivatization methods to chemically tag specific 
functional groups of lipids in the extracts[161]. During MS analysis, complexity can be 
reduced via intrasource separation or selective ionization. In addition, monitoring head 
group-related fragments that are characteristic to a specific lipid class by MS/MS, 
selectively detects molecular species within the class without interference from other 
coexisting classes[162]. 
On the other hand, the hyphenated technique of HPLC and ESI-MS has become the 
most widely used method in chromatography-based lipidomics analysis. Selection of a 
suitable column, optimization of the separation conditions, and appropriate coupling of 
the LC elution conditions with the MS are essential factors to achieve the best 
separation of lipid classes and/or lipid molecular species. The use of various types of 
columns have been reported for different purposes in lipidomics. This includes normal 
phase, reversed phase, hydrophilic interaction, ion exchange, affinity, in addition to 
multidimensional LC[163]. A general approach is to use normal-phase liquid 
chromatography (NPLC) to separate different classes of lipids based on the polar head 
groups, while reversed-phase liquid chromatography (RPLC) is often used to separate 
different molecular species in one class based on the different fatty acyl chains[164]. 
In contrast to shotgun lipidomics, LC-MS methodology has the characteristic feature of 
changing lipid concentrations in eluents. Hence, identification and quantification of 
lipid species have to be done “on-the-fly”, i.e. in a limited time frame[145]. 
Imaging of lipids by mass spectrometry has been recently one of the most exciting areas 
of lipidomics research. The most promising advantage of MSI is the potential to 
perform lipid analysis, avoiding extraction and/or separation steps, and to display the 
in situ information[154]. Almost all types of ionization sources have been successfully 
Introduction 
35 
 
applied for MSI of lipids, such as MALDI[18], DESI[165], SIMS[166], and pressurized 
liquid extraction surface analysis[167]. A discussion of different MSI methods with a 
focus on MALDI MSI was presented in the first section of the introduction chapter 
(Chapter 1.2). 
1.4.3 Bioinformatics tools in lipidomics 
The study of lipidomics, especially non-targeted lipid analysis, has generated 
overwhelming amounts of data, which need bioinformatics technology to aid in data 
processing for acquiring meaningful biological information[154]. Development of 
lipid-centered databases and libraries has become an essential part of lipidomics 
studies. In the following, a few representative examples of widely used lipid-related 
databases are presented. 
Lipid Maps Structure Database (LMSD) is the largest public database in the world 
specifically for lipids. It is publicly available at www.lipidmaps.org/data/structure. It 
uses a hierarchical classification and a nomenclature based on a comprehensive 
classification scheme proposed by Lipid Maps. A unique Lipid Maps ID number 
assigned to individual lipid structure, reflects its position in the classification hierarchy. 
It also offers several online tools for viewing and drawing of lipid structures[168]. 
METLIN is a metabolomics database developed at the Scripps Research Institute. It is 
a comprehensive repository of metabolite information and tandem MS data and 
available online at https://metlin.scripps.edu. METLIN includes masses, chemical 
formulas, and structures for over 15,000 metabolites including numerous lipid species. 
Annotated metabolites including lipids are linked to outside resources such as the 
Human Metabolome Database (HMDB), which makes it easier to find further 
references about the metabolite[169]. 
HMDB is a comprehensive database of metabolites found in the human body, created 
by the Human Metabolome Project and is freely available online at 
http://www.hmdb.ca/. It contains the information on chemistry, clinical data, and 
molecular biology for more than 6500 metabolites including lipids[170]. 
METASPACE, a platform for metabolite annotation of high-resolution mass 
spectrometry imaging (HR MSI) data, has recently been developed. It is a part of the 
European project METASPACE and is freely available online at 
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http://metaspace2020.eu/#/about. The framework offers an open-data repository where 
the metabolite annotations from datasets provided by the community are public and can 
be browsed or exported by active users. It is the first comprehensive bioinformatics 
engine that allows FDR-controlled metabolite annotation for HR MSI data. It is based 
on the following principles: database-driven annotation by screening for metabolites 
with known sum formulas, an original metabolite-signal match (MSM) score 
combining spectral and spatial measures, and a novel target–decoy FDR-estimation 
approach with a decoy set generated via the use of implausible adducts[171]. 
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2 Aims and scope 
Cisplatin has been widely used for treatment of solid tumors, usually in combination 
with other drugs[172]. It induces apoptosis or necrosis of tumor cells mainly by binding 
to DNA and distorting its functions[173]. A serious clinical side effect of cisplatin 
treatment is nephrotoxicity, occurring in one third of the patients[174]. Accumulation 
of cisplatin in the kidney, its main route of excretion, has been reported and the renal 
damage mainly involves the proximal tubules[175]. This accumulation induces 
oxidative stress in the kidney and results in increased lipid peroxidation affecting 
membrane integrity and inducing alteration in the renal lipid profile[176].  
The use of MALDI MSI for spatial mapping of the distribution of lipids in tissues has 
gained increasing interest in recent years[68]. On the one hand, most of the lipid species 
are particularly suitable for MALDI MSI because they ionize easily and are abundant 
components of biological systems[177]. They also play essential roles in cell signaling 
and metabolism and are principal membrane components. On the other hand, MSI 
allows direct analysis of lipids in situ, which helps to distinguish their distribution 
within tissue substructures, such as kidney[178]. MSI of lipids in kidney tissue allowed 
to identify alterations during kidney disease[179] and acute renal injury[180]. 
Considering this, the aim of the first part of this work is to develop a method for 
mapping the composition of lipids in the kidney tissues of healthy control and cisplatin-
treated rats using MALDI MSI. This could help better understand cisplatin-induced 
alterations in the renal lipid profile and shed light on the underlying pathophysiological 
processes involved in the nephrotoxic effect of cisplatin therapy. 
The choice of the matrix compound and optimizing the deposition of the matrix solution 
is considered with the aim to enhance the sensitivity. The identification of the lipid ions 
based on their exact mass is supported by the high mass resolution and accuracy of the 
orbitrap MS. On-tissue MS/MS approaches including fragment ion imaging are 
employed to confirm the identification of the lipid species. The distribution of the 
identified lipids in control and cisplatin-treated tissues is compared to identify cisplatin-
induced renal effects. 
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On the other hand, the variable influence of several experimental and instrumental 
factors[181] results in non-linear variability in extraction, desorption, and ionization of 
analytes across the tissue[42]. This limits the use of image intensities of the species of 
interest obtained during MALDI MSI for intersample comparison[98]. Several methods 
have been described for signal normalization of MALDI MSI data to tackle the 
challenges of uncontrollable variability in signal intensity, which hinders its use for 
relative quantitative applications[69, 95, 98-105]. Among these approaches, the ones 
which employ the use of internal standards have gained particular importance, enabling 
pixel-by-pixel correction of raw intensities[42]. 
The second part of this work aims at developing a novel method for normalization of 
lipid signals using dual lipid-metal internal standards. The method is developed with 
the target to allow intersample comparison of lipid intensity in kidney tissues with 
relative quantification purposes.  The use of the inkjet printer as a cost-effective tool to 
automatically, homogenously, and reproducibly deposit the matrix and internal 
standards is considered. Total metal content determination using ICP-MS is used to 
confirm consistency of the matrix deposition in the different experiments. Finally, 
application of the developed method to normalize ion intensities of kidney lipids in 
control and cisplatin-treated rats is evaluated.
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3 Results and discussion 
3.1 Lipid imaging by MALDI LTQ Orbitrap mass spectrometry 
in kidney sections under cisplatin treatment 
3.1.1 Overview 
The antitumor agent cisplatin has been successfully employed for the treatment of many 
solid tumors. It exerts its cytotoxic effect by binding DNA in the nucleus and inducing 
either apoptosis or necrosis of tumor cells[173]. Other cytotoxic mechanisms of 
cisplatin possibly involve interactions with non-DNA targets, such as proteins[182] and 
lipids[183]. Nephrotoxicity is a limiting side effect associated with cisplatin-based 
therapy, and occurring in about one-third of the patients[174]. Accumulation of 
cisplatin is relatively higher in the kidney, its main route of excretion, in comparison to 
other organs. The renal damage involves an acute injury of the renal proximal 
tubule[174], where accumulation of cisplatin was found[175]. 
Several studies reported changes in the lipid profile of the kidney as a consequence of 
cisplatin-induced renal injury, this included increased lipid peroxidation and impaired 
cell membrane integrity[176]. Also, elevation of non-esterified fatty acids and 
triglycerides levels in kidney during cisplatin treatment was found[184]. Moreover, 
membranes of sensitive and resistant cells showed alteration in their phospholipid 
composition after cisplatin treatment[185]. 
The mapping of tissue lipids by MALDI MSI has gained increasing interest in recent 
years[68]. On the one hand, most of the lipid species are particularly suitable for 
MALDI MSI because they ionize easily and are abundant components of biological 
systems[177]. On the other hand, MSI allows direct analysis of lipids in situ, which 
helps to distinguish their distribution within tissue substructures, such as kidney[178]. 
Previous works have shown that mass spectrometry imaging of kidney lipids helped 
distinguish specific lipids within kidney substructures[178, 186] and identify alterations 
occurring during acute kidney injury[180] and other kidney diseases[179, 187, 188]. 
Considering this, screening the spatial distribution of kidney lipids could help 
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understand more about lipid alterations involved in cisplatin-induced nephrotoxicity 
and shed light on the biochemical and pathophysiological processes involved. 
In this section, a method for mapping of lipid composition in positive ion mode using 
MALDI-LTQ-Orbitrap in rat kidney sections was developed, including optimization of 
matrix deposition. 
The method was applied to examine the lipid profile in kidney sections of control and 
cisplatin-treated rats. High mass resolution and accuracy of MALDI-LTQ-Orbitrap, on-
tissue tandem MS measurements, and fragment ion imaging reinforced the 
identification of lipid species. Lipids showing modified renal distribution patterns due 
to cisplatin-induced nephrotoxicity were found. These species could serve as 
complementary tools for renal damage assessment or as therapeutic targets. 
3.1.2 Histopathological assessment of cisplatin-induced renal 
damage 
As mentioned earlier, it is well recognized that the proximal tubule is the major site of 
renal injury during cisplatin nephrotoxicity[174]. Impaired renal function associated 
with cisplatin treatment has been related to the activation of complex signaling 
pathways that lead to injury and death (necrosis and apoptosis) of the renal tubular 
cells[176, 189]. Morphological assessment of the optical microscope images of H&E-
stained kidney sections showed signs of renal damage in kidney section of cisplatin-
treated rat (Figure 9c, d) in comparison to control healthy tissue (Figure 9a, b). Signs 
of toxicity included protein casts, tubular necrosis, and tubular swelling (marked with 
arrows in Figure 9c, d), which were observed mainly in the cortex, corticomedullary 
junction, and outer medulla, where the proximal tubule is located. 
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Figure 9. Microscope images for hematoxilin-eosin stained kidney sections showing 
the morphology of renal cortex and medulla from control (a and b) and cisplatin-
treated (c and d) rats. Signs of cisplatin-induced renal damage are marked with 
arrows, e.g. showing protein casts. 
3.1.3 Evaluation of the matrix of choice 
The matrix is applied as fine spray in a quickly evaporating solution containing (0.1-
1%) TFA for positive ion mode analysis. Extracting the maximum amount of the 
analyte from the sample while minimizing its delocalization and ensuring homogenous 
crystallization is the aim of optimization of matrix application[55]. The choice of matrix 
is normally determined by the mass range over which the experiment is to be performed. 
For small and medium molecular weight masses either α-cyano-4-hydroxycinnamic 
acid (α-CHCA) at 10–20 mg mL-1 or 2,5-dihydroxybenzoic acid (DHB) at 40–100 mg 
mL-1 is often used[54]. 
Matrix composition was optimized by monitoring the mass range between 700 - 900 
m/z, where most of the signals belonging to tissue lipids could be detected[190]. Figure 
10 shows the off- and on-tissue averaged mass spectra generated in the same imaging 
measurement of a kidney section coated with DHB solution (60 mg mL-1 in 70% 
MeOH, 0.1% TFA). Signals of tissue lipids were evident through comparing the 
highlighted mass range in both spectra (Figure 10). Signals in the lower mass range 
(below m/z 700) are common to both spectra and could be attributed to a contribution 
of DHB matrix ions. 
Slight enhancement of the low mass range in the on-tissue spectrum with respect to the 
off-tissue spectrum was observed and could be explained due to additional contribution 
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of tissue signals like lysophospholipids (intermediates involved in biosynthesis and 
metabolism of phospholipids)[191]. 
 
Figure 10. Averaged off- and on-tissue mass spectra showing the signals of tissue 
lipids in the on-tissue spectrum (mass range 700-900 m/z). 
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Different concentrations of DHB and α-CHCA were tested to optimize the matrix 
deposition. The signal intensity and tissue images of lipids were consequently assessed. 
Control kidney samples were spray-coated with either DHB (20, 40, and 60 mg mL-1 
in 70% MeOH, 0.1% TFA) or α-CHCA (10 and 20 mg mL-1 in 60% ACN, 0.1% TFA). 
MALDI imaging experiments of the coated tissue sections were performed at 500 µm 
and TIC-normalized signal intensity of various endogenous lipids was compared for the 
different matrix compositions. Figure 11 illustrates the mean intensity values of seven 
tissue lipids, which were calculated from parallel sections from the same rat kidney 
(n=3). In a single measurement, the intensity value was generated by averaging 20 on-
tissue spectra. 
Most of the lipid species in Figure 11 showed significant signal enhancement with DHB 
in comparison to α-CHCA. PE(36:4) at m/z 778.476, PE(38:7) at m/z 800.460, and 
PC(36:3) at m/z 822.545 showed at least a two-fold increase in intensity with different 
concentrations of DHB (20, 40, 60 mg mL-1). LPC(18:0) at m/z 524.370, SM(d34:1) at 
m/z 741.533, and SM(d36:2) at m/z 835.668 also showed remarkable enhancement in 
 
Figure 11. Effect of matrix composition on the signal intensity of tissue lipids. Mean 
signal intensity of the following tissue lipids: m/z 524.370, m/z 741.533, m/z 
778.477, m/z 800.460, m/z 822.545, m/z 835.668 and m/z 925.523, in kidney sections 
spray-coated with different concentration of either DHB or α-CHCA, is shown.  
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intensity at higher concentrations of DHB (60 mg mL-1). Only a few lipids such as 
PI(38:4) at m/z 925.523, showed higher intensity with α-CHCA. 
Figure 12 shows the effect of varying number of deposition/drying cycles on the 
MALDI images of PE(38:7), PC(36:3), SM (d36:2), and PI(38:4). Several matrix 
deposition/drying cycle amounts of either DHB (60 mg mL-1 in 70% MeOH, 0.1% 
TFA), or α-CHCA (20 mg mL-1 in 60% ACN, 0.1% TFA) within each tissue (Figure 
12a and b), were applied. The first tissue (Figure 12a) received 10, 15 and, 20 cycles of 
DHB (each cycle consisted of 20s of deposition+ 20 s of drying), while the second one 
(Figure 12b) had 9, 12, and 15 cycles of α-CHCA (each cycle consisted of 40 s of 
deposition+ 20 s of drying). The use of less concentrated matrix solution required 
double the number of deposition cycles with no remarkable gain in spectral quality, 
hence higher concentration of both matrices was preferred to shorten the time needed 
for matrix application. In addition, quick solvent evaporation should minimize the 
delocalization of tissue lipids and limit it within the matrix crystals formed. 
The ion extracted images of the lipids in both tissues were normalized to identical color-
scale bars for each ion species to allow comparison of signal level. In general, the 
images showed higher signal of the lipids with DHB deposition (Figure 12c, e, g, i) in 
comparison to α-CHCA (Figure 12d, f, h, j), confirming the previous results in Figure 
11. Deposition of 15 cycles of DHB resulted in higher ion intensities, increasing the 
number of spray cycles did not further enhance ionization. On the other hand, optimum 
ionization for α-CHCA was obtained at 12 deposition cycles. 
Difficulties were encountered to reproducibly obtain a homogenous coat of α-CHCA 
due to repeated blocking of the airbrush; which resulted in sputtering of the matrix 
solution, complicated the estimation of the applied amount of matrix and reduced the 
reproducibility of ion intensities obtained in different measurements. 
On the other hand, DHB solution was more feasible to handle and showed consistently 
higher ion intensities for most of the lipids. Accordingly, application of 15 cycles (20s 
of deposition+ 20 s of drying) of 60 mg mL-1 DHB in 70% MeOH, 0.1% TFA was used 
for further analysis of the lipids in kidney tissues, and no further optimization of α-
CHCA was done. 
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Figure 12. Effect of the number of matrix deposition cycles on the ion extracted 
MALDI images of tissue lipids for two tissue sections spray-coated either with DHB 
or α-CHCA. (a & b) The optical images of the two kidney sections showing the 
number of cycles within each tissue.  MALDI images of m/z 835.668 (c & d), m/z 
925.523 (e & f), m/z 800.460 (g & h), and m/z 822.544 (i & j) for the two samples. 
3.1.4 Assessment of reproducibility  
To demonstrate the reproducibility of the method, the distribution and abundance of 
different tissue lipids in serial tissue sections (n=3) of a vehicle control kidney were 
assessed. Two tissues (Figure 13 a, d, g and b, e, h) were analyzed in two consecutive 
days at 100 µm resolution. Whereas the third tissue (Figure 13c, f, i) was stored at -80 
°C for two months, in order to check the method reproducibility over time, then it was 
spray-coated with the matrix and analyzed at lower resolution (185 µm). 
Depending on the measurement dimensions, the high mass resolution imaging analysis 
of a single kidney tissue at 100 µm resolution lasts for 12 h in average. For proper 
comparison of ion intensities, conventional total ion current (TIC) normalization was 
used to compensate for drifts in matrix deposition and variable instrumental 
performance over time[100, 106]. This was particularly relevant to compare the 
abundance and tissue distribution of tissue lipids in different samples as seen in Figure 
13. TIC-normalized images of m/z 524.370 (Figure 13a, b, c), m/z 778.476 (Figure 13d, 
e, f), and m/z 822.544 (Figure 13g, h, i) showed comparable tissue localization with 
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clearly defined cortical and medullar distributions. Also, similar relative ion intensities 
were observed in the three samples, indicating that the method is reproducible and 
robust over time. 
 
Figure 13. TIC-normalized MALDI images show the reproducibility of distribution 
and relative intensity of m/z 524.370 (a, b, c), m/z 778.476 (d, e, f), and m/z 822.544 
(g, h, i) in 3 parallel sections in the same kidney tissue. Two tissues were measured 
at 100 µm resolution ((a, d, g), (b, e, h)), and the third at 185 µm (c, f, i). 
3.1.5 Assignment of lipids  
Lipids are produced during MALDI imaging mainly as highly abundant singly charged 
ions in the m/z range between 700 to 900[190]. Most lipids have characteristic features 
which increase the certainty of their identification using high-performance mass 
spectrometers with sufficient mass resolution. These features include the relatively high 
mass defect resulting from the contribution of large number of hydrogen atoms present 
in the acyl chains of the fatty acids. Also, the high number of carbon atoms results in a 
characteristic isotopic pattern, where a relatively high abundance of the ion at 1 Da 
higher in mass is observed, due to the abundance of carbon-13 found in nature (1.1 % 
relative abundance)[156]. The high mass resolution and accuracy provided by LTQ 
orbitrap instrument allowed the identification of lipids based on the exact mass of the 
monoisotopic signal of the precursor ion. Mass lists from MALDI measurements of 
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control and cisplatin-treated samples were used for exact mass search in LIPIDS MAPS 
(www.lipidmaps.org) with a tolerance window of 5 ppm. 
3.1.6 The role of high resolution MS (HRMS) and MS/MS imaging  
Identification of lipids in complex biological samples solely based on database search 
using the m/z value of the monoisotopic peak is often times inconclusive. In many 
cases, the database search could return several matching hits including: different lipid 
species having an exact mass value within the specified tolerance window (with 
different empirical formulas), isobaric species from different classes (with the same 
empirical formula, such as PC and PE), and isomers from the same lipid class. The high 
mass accuracy provided by the Orbitrap mass analyzer allowed a narrow tolerance 
window of 5 ppm, which reduced the search results.  Also, ion images of various 
adducts of the lipid species (H+, Na+, and K+) showed corresponding distribution 
patterns in the tissue, which reinforced the lipid identity. More importantly, direct on-
tissue MS/MS analysis was invaluable to identify and differentiate isobaric species, 
where daughter ions in the MS2 spectrum allowed recognize characteristic 
fragmentation patterns of the different lipid subclasses (e.g. NL of 43 for PE species 
and 59, 183 for PC species). 
In this section, some examples demonstrate the usefulness of high mass resolution, on-
tissue MS/MS, and fragment ion imaging to improve the certainty of lipids 
identification. 
The high performance of Orbitrap detection allowed complete resolution of precursor 
ions with close m/z values, thus, their respective tissue localization could be visualized 
in the MALDI image. The full MS spectrum in Figure 14b shows complete resolution 
of the precursor ions of [PS(38:5) + K]+ at m/z 848.4827 and [PC(38:4) + K]+ at m/z 
848.5561 with a mass difference of 0.0734 Da. The ion extracted images of both species 
(Figure 14a) show their tissue distribution and the difference in their relative 
abundance. On-tissue MS/MS analysis showed that the two precursor ions are mixed in 
the ion trap and the MS2 spectrum showed product ions belonging to both species 
(Figure 14c). The MS2 spectrum of the isolated precursor ion at m/z 848 at CID 35.00 
in Figure 14c shows fragment ions corresponding to the loss of trimethylamine (at m/z 
789.482 equivalent to [M+K-59]+) and phosphocholine (at m/z 665.490 equivalent to 
[M+K-183]+) for [PC(38:4) + K]+ at m/z 848.5561. In addition, the fragment ion at m/z 
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761.449 equivalent to the loss of serine (NL87) confirmed the assignment of [PS(38:5) 
+ K]+ at m/z 848.4827. It could be observed that the product ions were present at a 
relative abundance ratio consistent to that of the parent ions. 
Another example illustrated the usefulness of fragment ion imaging for lipid mapping 
(Figure 15). MALDI images of the fragment ions at m/z 789.482 and m/z 665.490 
(Figure 15b and c) showed similar tissue localization to that of the precursor ion 
[PC(38:4) + K]+ at m/z 848.5561(Figure 15a). Whereas, the distribution of the fragment 
ion at m/z 761.449 (Figure 15e) was analogous to its precursor ion [PS(38:5) + K]+ at 
m/z 848.4827(Figure 15d). Hence, the same distribution of PC(38:4) and PS(38:5) 
could be obtained in the MS and the MS/MS images. This suggested fragment ion 
mapping as a reliable strategy for confirmation of lipid assignment, which could be 
particularly useful where isobaric interferences might be significant.  
 
Results and discussion 
49 
 
 
Figure 14. (a) MALDI images of [PS(38:5) + K]+ at m/z 848.4827 and [PC(38:4) + 
K]+ at m/z 848.5561. (b) MALDI Full MS spectrum showing complete resolution of 
m/z 848.4827 and m/z 848.5561. (c) MALDI-CID-MS2 spectrum of m/z 848. 
Assignment of the most relevant fragment ions at m/z 789.482, m/z 665.490, and m/z 
761.449 has been indicated. 
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Figure 15. Fragment ion imaging shows similar tissue distribution of precursor and 
fragment ion. (a and d) TIC-Normalized MALDI images show the renal distribution 
of m/z 848.5561 and m/z 848.4827. (b and c) MALDI image showing distribution of 
fragment ions at m/z 789.482 and m/z 665.490 (precursor ion m/z 848.5561). (e) 
MALDI image showing distribution of fragment ion at m/z 761.449 (precursor ion 
m/z 848.482).  
In other cases, the assignment of several NL in the MS2 spectrum allowed identify 
isobaric species. The MALDI-CID-MS2 spectrum of the isolated ion at m/z 796 in 
Figure 16a showed typical NL of trimethylamine (at m/z 737.451 corresponding to 
[M+K-59]+) and phosphocholine head group (at m/z 613.458 corresponding to [M+K-
183]+), which concluded the assignment of [PC(34:2) + K]+ at m/z 796.524. On the 
other hand, the fragment ion at m/z 753.480, which is equivalent to [M+K-43]+ 
indicating NL of vinyl amine, confirmed the assignment of [PE(37:2) + K]+ with the 
same exact mass. The low relative abundance of the daughter ion at m/z 753.480 
suggested that PC(34:2) would be the main species represented in the MALDI image 
(Figure 16b). 
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The previous findings showed that careful interpretation of on-tissue MS/MS data is 
essential for unambiguous identification of lipid species. In most of the cases, MS/MS 
analysis led to the assignment of the lipid family. In other cases, lipids were present at 
a relatively low abundance, which complicated the isolation of the precursor ion in the 
ion trap, hence, no useful fragmentation could be obtained and only putative 
identification was used. 
3.1.7 Lipid imaging for screening of cisplatin-induced effects 
Comparison of TIC-normalized images of lipid ions detected in positive ion mode 
analysis in control and cisplatin-treated kidney samples was performed to explore the 
ones showing difference in tissue distribution, which could be attributed to cisplatin 
effect. H&E staining images of serial tissue sections were compared alongside with 
MALDI images for proper comparison and identification of renal structures. This 
resulted in a total of 20 lipid species (comprising 45 ion adducts), which revealed clear 
differences in tissue localization under cisplatin treatment with respect to healthy 
control samples. Table 2 shows a list of the lipids showing differential tissue 
distribution in control and cisplatin-treated samples in positive ion mode. The listed 
lipids comprised 12 PC, 2 PE, 2 PI, 1 SM, 1 LPC, 1 PG, and 1 SM. As seen in Table 2, 
 
Figure 16. (a) MALDI CID-MS2 spectrum of m/z 796.524 showing the assignment 
of several NL, which indicated the presence of isobaric species. The transitions m/z 
796.524→737.451 and m/z 796.524→613.458 indicate PC(34:2), while the transition 
m/z 796.524→753.480 indicates PE(37:2). (b) Ion extracted image of m/z 796.524. 
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some of the lipids could be found in multiple ionization states (H+, Na+, and K+ 
adducts). In addition, some PC species underwent in-source fragmentation (NL of 59 
corresponding to trimethylamine), which resulted in the detection of [(M-59) + Na/K]+ 
adducts. 
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Observed 
m/z 
Adduct Assignment, 
empirical formula 
Calculated m/z ∆m, 
ppm 
524.3706 [M+H]+ 
LPC(18:0) 
C26H54NO7P 
524.3711 -0.89 
697.4774 [M+Na-59]+ 
PC(32:0) 
C40H80NO8P 
697.4779 -0.68 
713.4526 [M+K-59]+ 713.4518 1.10 
734.5698 [M+H]+ 734.5694 0.50 
756.5525 [M+Na]+ 756.5514 1.48 
772.5267 [M+K]+ 772.5253 1.79 
770.5101 [M+K]+ 
PC(32:1) 
C40H78NO8P 
770.5096 0.65 
800.5585 [M+K]+ 
PC(34:0) 
C42H84NO8P 
800.5566 2.37 
723.4929 [M+Na-59]+ 
PC(34:1) 
C42H82NO8P 
723.4935 -0.86 
739.4664 [M+K-59]+ 739.4675 -1.44 
760.5835 [M+H]+ 760.5851 -2.08 
798.5420 [M+K]+ 798.5410 1.30 
  
Table 2. Lipids showing differential renal distribution in control and cisplatin-treated 
samples. Observed m/z, adduct type, lipid species, empirical formula, calculated m/z, 
and error in ppm according to LIPID MAPS assignment are shown. * indicates putative 
assignment for species with no useful fragmentation data. 
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Observed 
m/z 
Adduct Assignment, 
empirical formula 
Calculated m/z ∆m, 
ppm 
721.4812 [M+Na-59]+ PC(34:2) 
C42H80NO8P 
721.4778 4.71 
737.4499 [M+K-59]+ 737.4518 2.57 
758.5722 [M+H]+ 758.5694 3.69 
780.5533 [M+Na]+ 780.5513 2.56 
796.5282 [M+K]+ 796.5253 3.64 
763.4696 [M+K-59]+ PC(36:3) 
C44H82NO8P 
763.4675 2.80 
822.5447 [M+K]+ 822.5410 4.54 
761.4524 [M+K-59]+ 
PC(36:4) 
C44H80NO8P 
761.4518 0.77 
804.5514 [M+Na]+ 804.5514 -1.84 
820.5244 [M+K]+ 820.5253 -1.12 
802.5355 [M+Na]+ PC(36:5) 
C44H78NO8P 
802.5357 -0.28 
818.5074 [M+K]+ 818.5097 -2.77 
810.5996 [M+H]+ 
PC(38:4) 
C46H84NO8P 
810.6007 -1.40 
832.5812 [M+Na]+ 832.5827 -1.78 
848.5561 [M+K]+ 848.5566 -0.61 
856.5814 [M+Na]+ PC(40:6) 
C48H84NO8P 
856.5827 -1.49 
872.5584 [M+K]+ 872.5566 2.04 
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Observed 
m/z 
Adduct Assignment, 
empirical formula 
Calculated m/z ∆m, 
ppm 
870.5407 [M+K]+ 
PC(40:7) 
C48H82NO8P 
870.5410 -0.30 
854.5715 [M+H]+ * PC(42:10) 
C50H80NO8P 
854.5695 2.34 
892.5234 [M+K]+ 892.5254 -2.22 
762.5057 [M+Na]+ PE(36:4) 
C41H74NO8P 
762.5044 1.76 
778.4769 [M+K]+ 778.4783 -1.81 
784.4879 [M+Na]+ PE(38:7) 
C43H72NO8P 
784.4888 -1.10 
800.4603 [M+K]+ 800.4627 -3.00 
762.4540 [M+Na]+ 
* PI-Cer(t30:1) 
C36H70NO12P 
762.4528 1.57 
817.4381 [M+K]+ 
* PG(37:7) 
C43H71O10P 
817.4416 -4.28 
909.5472 [M+Na]+ PI (38:4) 
C47H83O13P 
909.5464 0.93 
925.5233 [M+K]+ 925.5203 3.25 
815.6999 [M+H]+ 
SM (d42:1) 
C47H95N2O6P 
815.7001 -0.19 
837.6801 [M+Na]+ 837.6820 -2.27 
853.6564 [M+K]+ 853.6559 0.54 
931.5281 [M+Na]+ * PI(40:7) 
C49H81O13P 
931.5307 2.79 
947.5040 [M+K]+ 947.5046 -0.67 
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Figures 17 and 18 illustrate examples of the remarkable differences in renal localization 
of some lipids in cisplatin-treated tissues in comparison to control tissue. MALDI 
images show the tissue distribution of some lipids in control (Figure 17 & 18 n, o, p, q, 
r) and two cisplatin-treated tissues, which are obtained from two rats (first: Figure 17 
& 18 b, c, d, e, f, and second: Figure 17 & 18 h, i, j, k, l). Both cisplatin-treated tissues 
showed the same trend in lipid distribution change with respect to the control sample, 
which confirmed the consistency of the results. Also, comparable ion images of the 
lipids in the cisplatin-treated tissues indicated the reproducibility of the results, showing 
corresponding localization and normalized relative abundance. 
Ion images of lipids showed several patterns of change in control and cisplatin-treated 
samples. Some lipids showed relatively higher levels in the cortex of control samples, 
such as PC(38:4), Figure 17r, and  PC(32:0), Figure 17p. After cisplatin treatment, the 
two species showed either higher medullar levels (PC(38:4), Figure 17f, i), or 
homogenous tissue distribution (PC(32:0), Figure 17d, j). 
Other species showed different pattern of change with a trend of displacement towards 
the cortex after cisplatin treatment (e.g. (PE(36:4), Figure 17b, h), (PG(37:7), Figure 
17e, k), (PI(38:4), Figure 18b, h), and (PC(36:5), Figure 18e, k)). In the healthy sample, 
those species were either homogenously distributed in the tissue ((PE(36:4), Figure 
17n), (PG(37:7), Figure 17q), and (PI(38:4), Figure 18n)), or showed higher local 
abundance in the outer medulla ((PC(36:5), Figure 18q). Also, some lipids were located 
in the inner medulla and cortex of the healthy sample (e.g. (PC(32:1), Figure 17o), 
(PC(34:1), Figure 18o), and (LPC(18:0), Figure 18p)), whereas in the cisplatin-treated 
samples, they were mostly present in the outer medulla and cortex ((PC(32:1), Figure 
17c, i), (PC(34:1), Figure 18c, i), and (LPC(18:0), Figure 18d, j)). The observed 
alterations in lipid renal distribution in cisplatin-treated samples might be a result of 
cisplatin-induced nephrotoxicity.  
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Figure 17. H&E-stained whole kidney sections for two cisplatin-treated samples (a 
and g) and control (m) showing, C: cortex, CMJ: corticomedullary junction, M: 
medulla, and P: pelvis. Positive ion mode lipid MALDI images show the renal 
distributions of PE(36:4) (b, h, n), PC(32:1) (c, i, o), PC(32:0) (d, j, p), PG(37:7) (e, 
k, q) and PC(38:4) (f, l, r) in the three samples at 100 μm resolution. 
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Figure 18.  H&E-stained whole kidney sections for two cisplatin-treated samples (a 
and g) and control (m) showing, C: cortex, CMJ: corticomedullary junction, M: 
medulla, and P: pelvis. Positive ion mode lipid MALDI images show the renal 
distributions of PI(38:4) (b, h, n), PC(34:1) (c, i, o), LPC(18:0) (d, j, p), and PC(36:5) 
(e, k, q) in the three samples at 100 μm resolution. 
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3.1.8 Significance of cisplatin-induced alterations of tissue lipids  
The lipid species with altered renal tissue distribution in Table 2, are 
glycerophospholipids (GPLs), most of them belonging to the PC lipid subclass, which 
are principal membrane components[192]. Impaired cell membrane integrity resulting 
from peroxidation of cellular membrane lipids was reported as a consequence of 
cisplatin treatment[176]. This suggested the possible dysregulation or release of 
membrane GPL during cisplatin-induced cell death. In addition, the anatomical 
differentiation of lipids in cisplatin-treated samples was mainly observed in the cortex 
and the outer medulla, which agreed well to the histological damage reported in the 
proximal tubule[174], and also to the local renal accumulation of cisplatin in the cortex 
and corticomedullary junction[175]. 
Many of the altered species showed either a homogenous tissue distribution (e.g 
PC(32:0), Figure 17d, j)), or an increase in relative abundance in the medulla of 
cisplatin-treated kidney (e.g. (PC(38:4), Figure 17f, i), which could indicate possible 
migration of the lipids from the dead proximal tubule. On the other hand, some PC 
species showed different patterns of change with local relative increase of abundance 
in the cortex after cisplatin treatment (e.g. (PC(36:5), Figure 18e, k), and (PE(36:4), 
Figure 17b, h)), which could be explained due to the distorted membrane 
permeability[176]. It is worth to mention that the change pattern of PC(32:0) (Figure 
17d, j) with a homogenous distribution and decreased relative abundance in the cortex 
under cisplatin treatment agreed to the results reporting its total decrease in human 
embryonic kidney cisplatin-treated cells (HEK293)[193]. Also, PC(36:5) (Figure 18e, 
k) showed increased relative abundance in the cortex of cisplatin-treated samples, 
which matched its increase in the same report as well[193]. Additionally, the 
displacement of LPC(18:0) (Figure 18d, j) towards the outer medulla in the cisplatin 
treated kidney, could support the study proposing several LPC species as plasma 
biomarkers of nephrotoxicity during cisplatin treatment[194]. This change suggests 
further research to investigate if a correlation between the changes in tissue distribution 
of renal lipids and circulating lipids could exist.  
On the other hand, PI species are involved in several cell signaling pathways[195]. 
Also, they act as precursors for lipid protein kinases, which are involved in mediating 
the renal tubular injury and play a critical role in the maintenance of renal function in 
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cisplatin-induced acute renal failure in vivo[196]. This could explain the alteration 
observed for some PI species (e.g. PI(38:4), Figure 18b, h) under cisplatin treatment 
with a general trend of localizing in the cortex and outer medulla of the treated kidney. 
3.1.9 Conclusion and outlook 
A simple and robust sample preparation protocol has been developed for imaging of 
lipids in the kidney sections of healthy control and cisplatin-treated rats using MALDI 
LTQ Orbitrap MS. Applying the developed method, imaging measurements of control 
kidney tissues showed reproducible distribution and relative abundances of lipids. The 
high mass resolution and accuracy of the Orbitrap allowed accurate mass assignment 
of the lipids. In addition, on-tissue MS/MS measurements and fragment ion imaging 
further confirmed the assignment of most of the detected lipids. Comparing the 
distribution of the renal lipids in control and cisplatin-treated samples resulted in 20 
lipid species showing clear differences in the examined kidney sections from both 
groups. The change in tissue distribution of the lipids in the cisplatin group could be 
explained based on the nephrotoxic effect of cisplatin therapy. This suggests that 
MALDI imaging could serve as a useful complementary tool for clinical diagnostics, 
which provides spatial information that contributes to the understanding of lipid 
signaling pathways and mechanisms involved in proximal tubule cell death associated 
with cisplatin treatment.  
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3.2 Dual internal standards with metals and molecules for 
MALDI imaging of kidney lipids 
3.2.1 Overview 
Matrix-assisted laser desorption ionization mass spectrometry imaging (MALDI MSI) 
provides a powerful tool for non-targeted analysis of drug[197, 198], protein[199, 200] 
lipid[122, 156], and metabolite[99, 201] distribution in biological tissues. In contrast to 
classic histological techniques, imaging of molecular species can be performed without 
chemical modification[38]. MALDI MSI has been employed for studying the 
distribution of endogenous lipids in tissue such as kidney[42, 178, 180, 202]. 
Comparison of biomolecules distribution in tissue sections is a powerful tool to discern 
between healthy and disease tissue states[202]. In the previous section of this work 
(3.1), MALDI MSI was employed to visualize the alterations in the distribution of 
kidney lipids induced by cisplatin treatment. 
A major challenge still is the combination of MSI and quantification. The use of the 
image intensities for inter-tissue comparisons is difficult due to the variable influence 
of experimental and instrumental factors[42, 98, 181]. In addition, sample-originated 
matrix effects, including tissue surface microenvironment, result in inhomogeneous 
matrix-analyte crystal formation. Subsequently, non-linear variability in extraction, 
desorption and ionization of analytes across the tissue can be found[42]. 
Several normalization methods have been described for MALDI MSI to address the 
variability in signal intensity[69, 95, 98-105]. This includes the often used 
normalization to total ion current (TIC)[100, 106], with limited reliability[95, 98]. Also, 
normalization to matrix related peaks[99] was used for correction of uneven matrix 
thickness and crystallization. However, this method assumes that endogenous 
biomolecules respond evenly to changing matrix conditions, limiting the success of this 
approach as well[3]. Other methods implement normalization algorithms based on 
noise levels, and median signal intensity of the spectrum[98, 100]. However, the most 
promising approaches for MSI signal normalization seem to be those applying internal 
standards, enabling pixel-by-pixel correction of raw intensities and allowing reliable 
relative quantification[42]. 
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Approaches that include the use of different internal standards have been reported for 
signal normalization of compounds in tissue as well as endogenous tissue components. 
Spray-deposition of levofloxacin as a reference standard was reported to normalize the 
distribution of the anti-TB drug, moxifloxacin[103]. Also, an inkjet printer was used to 
apply a deuterated analogue of acetyl-L-carnitine separately from the spray-coated 
matrix to study tissue-specific ionization differences[104]. With an ImagePrep station, 
standard peptides were applied as internal calibrants for normalizing imaging data sets 
from tryptic peptides[105]. Inkjet printing of non-endogenous lipids as internal 
standards was also reported to quantify lipids in nerve tissue[69]. 
In this respect, the optimization of matrix deposition is crucial because it affects the 
extraction and desorption of the analytes across the tissue surface, which in turn affects 
the resulting spectral quality and image reliability. Several studies reported the use of 
commercially available inkjet printers for quantitative applications in mass 
spectrometry imaging[69, 104, 203-205], because they provide a low cost technique for 
reproducible and homogenous matrix application. 
In this section, a novel method for controlled and reproducible application of matrix 
and internal standards on kidney sections was developed, allowing normalization of 
lipid signals and intersample comparison of MALDI MSI data on relative quantitative 
basis. Two non-endogenous phospholipids, PE(15:0/15:0) and PC(21:0/21:0), were 
chosen as primary internal standards. An inkjet printer was used for automatic and 
homogenous application of matrix and internal standards[69, 204]. Samples were 
prepared simultaneously and matrix application was controlled using a secondary 
internal standard. For this purpose, a monoisotopic lanthanide salt was spiked to the ink 
and printed together with matrix and the internal standard lipids onto nitrocellulose 
(NC) membranes placed close to the tissue sections. Total metal content determination 
by inductively-coupled plasma mass spectrometry (ICP-MS) was performed to monitor 
the reproducibility of the matrix deposition. 
The dual lipid-metal internal standard normalization method was evaluated by 
comparing the raw, TIC-normalized, and internal standard-normalized distributions and 
intensities of kidney lipids. The primary internal standards (non-endogenous 
phospholipids) were used to normalize lipid signals. With vehicle control tissues, we 
ensured that no isobaric species were apparent. To control the reproducibility and 
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homogeneity of matrix and internal standards printing, a spiked lanthanide was used as 
a secondary internal standard and quantified using ICP-MS, which is regarded here as 
orthogonal analytical method to MALDI MS. 
3.2.2 Optimization of printing conditions and customized ink 
Careful adjustment of the solvent composition was necessary to dissolve the internal 
lipid standards in the matrix solution. First, an attempt to use conventional ink as the 
dissolving medium was done; however, turbidity occurred because inks are sensitive to 
increased concentrations of dissolved salts. Also, strong background signals (polymeric 
pattern signals in the mass range 400-1200 m/z) that overlap with the mass range of 
lipids were detected (Figure 19-I). To optimize a customized solution, different 
MeOH:H2O ratios (20:80, 50:50, and 70:30) were experimented, which resulted 
eventually, in complete solubility of the internal lipid standards and the most 
homogenous print coating. Higher MeOH content (70%) and slight heating of the 
microscope slides for 5 s before printing contributed to faster drying and clearly 
improved the homogeneity of the printed matrix coating (Figure 19-II and III). 
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Figure 19. I) Mass spectrum showing background signals when colorless or yellow 
ink were used to dissolve DHB and the internal standards. II) Effect of increasing 
organic solvent composition on the homogeneity of the resulting printing output, 
where A, B, and C have 20%50% 70% MeOH, respectively. III) Digital microscope 
camera images showing matrix deposition after 5 printing cycles of ink solution 
(DHB = 120 mg mL-1 in 70% MeOH, 0.1% TFA). A) Pre-heating of the glass slide 
during 5s on a hot plate at 50 ˚C before each printing cycle, and B) at room 
temperature. 
Control MALDI measurements showed that the printer-based method led to a much 
lower deposition compared to air-brush nebulizers, hence the concentration of DHB in 
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the matrix solution was higher (120 mg mL-1) than that previously described for 
airbrush deposition[202] to avoid long deposition times (Figure 20). 
 
Figure 20. Effect of increasing DHB concentration on the ionization of the internal 
standard. Extracted ion images of [M+K]+ of PE(15:0/15:0) internal standard at m/z 
702.447 obtained for (A): inkjet printer at 120 mg mL-1 DHB, and (B): air-brush 
nebulizer at 40 mg mL-1 DHB. Both tissues had 30 deposition passes and the same 
internal standard concentration. 
The effect of the number of printing cycles was monitored to optimize matrix and 
internal standards signal. A tissue section received 20 printing cycles on the left side 
and 30 on the right side, showed significant enhancement of the matrix and internal 
standards signals on the side receiving more printing cycles, while tissue lipids existing 
at different intensity levels showed adequate ionization (Figure 21). 
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Figure 21. The effect of the number of printing cycles on the extracted ion images of 
a kidney tissue section with 20 printing cycles on the left side and 30 on the right 
side. (A) DHB, ([2M-2H2O]+ at m/z 273.039). (B) [M+H]+ adduct of the PE 
(15:0/15:0) internal standard at m/z 664.491. (C) [M+H]+ adduct of the PC 
(21:0/21:0) internal standard at m/z 874.725. (D-F) Tissue lipids at m/z 741.533, 
782.567, and 822.542, respectively. 
Printing more than 30 cycles did not improve ion abundance. Intensity of matrix and 
internal standards, PE (15:0/15:0) and PC (21:0/21:0), showed increasing signals only 
up to 30 printing cycles. On the other hand, tissue lipids showed minimal change and 
stable ionization (Figure 22). The quality of mass spectra obtained from a kidney tissue 
upon printing 30 cycles of the optimized solution mixture is given in Figure 23. 
 
Figure 22. Kidney tissue section with 35 printing cycles on the left, 30 on the middle, 
and 25 on the right part. No enhancement of matrix and internal standard signal could 
be observed upon printing more than 30 cycles (A to C). (A) DHB, [2M-2H2O]+ (m/z 
273.039). (B) [M+H]+ adduct of the PE (15:0/15:0) internal standard (m/z 664.487). 
(C) [M+H]+ adduct of the PC (21:0/21:0) internal standard (m/z 874.725). (D to F) 
Tissue lipids showing stable ionization at m/z 741.528, m/z 782.565, and m/z 
822.542, respectively. 
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Figure 23. (A) Mass spectrum illustrates the spectral quality of a kidney tissue section 
printed with 30 cycles of matrix-internal standards mixture, tissue lipids are observed 
in the m/z range from 700-900. (B) H+, Na+ and K+ adducts of the lipidic internal 
standard PE (15:0/15:0) at m/z 664.491, m/z 686.470 and m/z 702.447, respectively. 
(C) H+ (m/z 874.725), Na+ (m/z 896.707), and K+ (m/z 912.680) adducts of the lipidic 
internal standard PC (21:0/21:0). 
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3.2.3 Reproducibility under optimized printing parameters and 
uniformity of internal standard on-tissue distribution 
Reproducibility of the optimized printing method was assessed in control tissue 
replicates, showing comparable signal intensity of the matrix, endogenous lipids and 
adducts of both internal lipid standards (Figure 24). Ion images of H+, Na+, and K+ 
adducts demonstrated the uniformity of on-tissue distribution of the printed internal 
standard lipids (Figure 25). Additionally, evaluation of the mean relative intensity in 3 
Regions Of Interest (ROI) -each consisted of 125 pixels- in different locations of the 
tissue section in Figure 25 showed a RSD value <10% for H+, Na+, and K+ adducts of 
both internal standards. 
 
Figure 24. Reproducibility of MALDI images is demonstrated in two kidney tissue 
sections printed according to the optimized parameters. (A) DHB signal at m/z 
273.039. (B) Endogenous lipid at m/z 741.533. (C) [M+K]+ of the PE (15:0/15:0) 
internal standard at m/z 702.447. (D) [M+Na]+ of the PC (21:0/21:0) internal standard 
at m/z 896.707. 
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3.2.4 Proof of concept 
Instrumental drifts 
To assess the potential of the internal standards to correct for signal variability 
associated with instrumental drifts, an experiment simulating the effect of varying laser 
energy was performed. Figure 26 illustrates the extracted ion images, where two halves 
of a single tissue section printed with the matrix-internal standards mixture were 
analyzed using different laser energies. For the upper half of the tissue, the laser energy 
was set to 27 µJ, while for the lower half it was set to 40 µJ, the latter being the optimal 
experimental condition for ionization. As expected, this resulted in different ionization 
efficiencies for the endogenous lipids as seen in three lipid ions at m/z 741.533, m/z 
782.567, and m/z 822.542, with lower ionization in the upper half (Figure 26A to C). 
Normalization of the endogenous lipids against signals of H+ and K+ adducts of the PC 
(21:0/21:0) internal standard led to comparable relative intensities in both halves 
(Figure 26D to I). 
 
Figure 25. (A-C) Ion extracted images showing on-tissue distribution of H+, Na+, and 
K+ adducts of IS PE (15:0/15:0) at m/z 664.491, 686.473, and 702.447, respectively. 
(D-F) Ion images showing on-tissue distribution of H+, Na+ and K+ adducts of IS PC 
(21:0/21:0) at m/z 874.725, m/z 896.707 and m/z 912.681, respectively. 
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This proves that a homogenously applied internal standard corrects for instrumental 
factors affecting ionization. The results of internal standard normalization are depicted 
in Figure 26 for three endogenous lipids at varying intensity levels with m/z 782.567 > 
m/z 741.533 > m/z 822.542 (approximate intensity range of 1 to 2 E6, 1.5 to 3 E5, and 
4 to 8 E4, respectively). The normalized relative intensity of lipids showed different 
levels in the images normalized to H+ and K+ adducts of PC (21:0/21:0). This could be 
explained due to different on-tissue abundance of both internal standard adducts. 
Nevertheless, correction using relative intensity worked successfully in both cases. 
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Figure 26. Extracted ion images show the effect of variation of laser energy on 
ionization. The upper half of the tissue was ablated at 27 µJ, and the lower half at 40 
µJ. Tissue lipids (m/z 741.533, 782.567, and 822.542, respectively) are displayed, 
either unnormalized (A to C), or normalized to H+ and K+ adducts of PC (21:0/21:0) 
internal standard at m/z 874.725 (D to F) and m/z 912.681 (G to I), respectively. 
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Methodological drifts 
The potential of internal standards to correct for signal variability originated from 
experimental inconsistency between measurements was evaluated. Different matrix-
internal standard mixture depositions were used, and the effect on the endogenous lipids 
ionization profiles was checked, details are shown in Figure 27. A control tissue was 
printed with matrix-internal standards mixture, the left half receiving 30 cycles of 
printing, and the right one only 15. Then, each part of the tissue was analyzed 
separately. MALDI images showed that the endogenous lipids were differently affected 
by the change in matrix-internal standards amounts, where more abundant lipids (m/z 
782.567) became enhanced with more printing passes, while lipids with medium and 
lower relative abundance (m/z 741.533, 822.542), showed little or no enhancement, 
with some signal suppression even being observed. Obviously, normalization to the 
internal standards did not correct for this variation (Figure 27). 
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Figure 27. Color codes illustrate the effect of a proportional variation of matrix and 
internal standards amounts. Endogenous lipids with high, medium and low 
abundance are shown in panels A, B and C, respectively. Panels D, E and F show the 
same m/z images corrected by [M+K]+ of PC internal standard, m/z 912.681. 
Hence, a secondary internal standard was added to the mixture to control the printing 
reproducibility. Thulium (169Tm) was spiked to the ink in a final concentration of 1 mg 
L-1, and a NC membrane was fixed to the glass slide close to the tissue section, to be 
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printed in one experiment. Afterwards, membranes were collected, mineralized and 
analyzed by direct injection ICP-MS for absolute quantification of the metal deposited, 
which correlates to the absolute amount of matrix and internal standards. The amount 
of Tm in NC membranes in different experiments showed a mean value of 279 pg Tm 
per mg membrane with a relative standard deviation of 10-15%, as can be seen in Figure 
28. 
 
Figure 28. Metal amounts in mineralized membranes printed simultaneously with the 
tissues. Nitrocellulose membrane from each printing experiment weighed approx. 2-
4 mg. Metal content in the different samples showed a mean value of 277 pg (Tm) / 
mg (membrane) with a RSD value of 11%. Error bars indicate the s.e.m where the 
mean value in each sample is calculated using 3 replicates. 
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In addition, LA-ICP-MS of NC membranes demonstrated the good homogeneity of 
metal distribution (Figure 29), where signal intensity showed RSD value of 2-4% 
between the different ablated lines within the membrane, which supports the results 
obtained on-tissue (Figure 25). 
 
Figure 29. Intensity profile of 169Tm using LA-ICP-MS of a 2 mm2 area of a NC 
membrane, which received 30 printing cycles of the optimized matrix/internal 
standards mixture. RSD value of 2-4% was found between the different ablated lines 
within the membrane.  
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3.2.5 Application for intratissue or intrameasurement correction 
Effect of the internal standard adduct type and chemical class 
Next, the raw intensity of various lipid species was normalized to those of the different 
internal standards adducts, and the resulting images were compared to their TIC-
normalized image. Figure 30 shows normalization of the raw intensities of m/z 760.587 
([M+H]+ (PC (34:1), ∆m=2.50 ppm) to the H+, Na+, and K+ adducts of both 
PE(15:0/15:0) and PC(21:0/21:0) internal standards (Figure 30D to I), and TIC-
normalization (Figure 30C). The optical tissue image showed several irregular locations 
on tissue surface caused by small folds or surface irregularity (arrows in Figure 30A). 
In general, higher ion abundance in the medulla relative to the cortex was visible in all 
normalized images. However, normalization to H+ adducts of both internal standards 
(Figure 30D and G) preferentially showed higher intensity at locations of the artifacts, 
even when the overall relative intensity was not the highest, improving the correlation 
of MALDI image to optical image[206]. The corrections based on Na+ and K+ adducts 
of the internal standards showed the highest overall normalized intensity with less 
differentiation of the tissue folds (Figure 30E, F, H, I); the same holds true for the raw 
and the TIC-normalized images (Figure 30B and C).  Hence, it would be preferable to 
normalize the intensity of a certain lipid adduct to an internal standard ion of the same 
lipid class and adduct type, considering the dependence of adduct formation on the lipid 
type and the abundance of Na+/K+ in the tissue microenvironment. 
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Figure 30. Effect of internal standard adduct type on the normalized images of 
[M+H]+ of PC(34:1) at m/z 760.587. (A) Optical scan of the measured tissue. (B) 
Raw MALDI image. (C) TIC-normalized image. (D-F) Images normalized to 
[M+H]+, [M+Na]+, and [M+K]+ of PE(15:0/15:0) at m/z 664.491, 686.473, and 
702.447, respectively. (G-I) Normalized images to [M+H]+, [M+Na]+ and [M+K]+ of 
PC(21:0/21:0) at m/z 874.725, 896.707 and 912.681, respectively. 
Even for lipid classes unequal to the internal standards, the beneficial effect was still 
visible on comparing the raw, TIC-normalized, and internal standard-normalized ion 
images of m/z 909.547 (PI(38:4), [M+Na]+, ∆m=0.93 ppm) in the same tissue section 
(Figure 31). Images normalized to the different internal standard adducts showed the 
same qualitative tendency reflecting accurately tissue irregularities in the optical image, 
and presented clear improvement in comparison to the raw and TIC-normalized images 
(Figure 31). 
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Figure 31. Improved reflection of tissue irregularities observed in internal standard 
normalized MALDI images for m/z 909.547 (PI(38:4), [M+Na]+). (A) Optical scan 
of the measured tissue. (B) Raw MALDI image of m/z 909.547. (C) TIC-normalized 
image. (D to F) Normalized images of m/z 909.547 to [M+H]+ , [M+Na]+ and 
[M+K]+ of PE (15:0/15:0) at m/z 664.491, m/z 686.473, and m/z 702.447, 
respectively. (G to I) Normalized images of m/z 909.547 to [M+H]+, [M+Na]+ and 
[M+K]+ of  PC(21:0/21:0) at m/z 874.725, m/z 896.707 and m/z 912.681, 
respectively. 
Additionally, the signal stability of different species was analyzed for more appropriate 
assessment of the internal standard normalization effect. Intensity analysis of 
[PE(36:4)+K]+ at m/z 778.478 and [PC(32:1)+Na]+ at m/z 754.536 in several locations 
in the tissue section, including tissue folds and different kidney regions (cortex and 
medulla), showed a particularly improved signal stability when normalization to an 
internal standard adduct of similar ion type was used (Figure 32); concluding adduct 
type as crucial for appropriate normalization. 
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Figure 32. Mean relative intensity calculated in different ROIs in the tissue section 
for m/z 778.478 and m/z 754.536 (marked in magenta: Fold, Medulla and Cortex, 
each ROI contains approx. 100 pixels). The tables show average, standard deviation 
and relative standard deviation for non-normalized, TIC-normalized and different 
internal standards adducts–normalized intensity at m/z 664.491, m/z 686.473, m/z 
702.447, m/z 874.725, m/z 896.707 and m/z 912.681, corresponding to [M+H]+, 
[M+Na]+, [M+K]+ for PE(15:0/15:0) and PC(21:0/21:0), respectively. 
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Structure and condition of the tissue 
The internal standard-normalized MALDI image in the upper panel in Figure 33D 
demonstrated a clearer lipid distribution within the kidney structures in comparison to 
the raw image (Figure 33B). Normalization of m/z 758.570 (PC (34:2), [M+H]+, ∆m = 
0.66 ppm) to H+ adduct of PC at m/z 874.725 (Figure 33D) reflected the differential 
distribution in the inner medulla (IM), the inner and outer stripes of the outer medulla 
(OM), in addition to the cortex; as indicated in the H&E image (Figure 33A). This was 
also seen in the TIC-normalized image (Figure 33C). 
Another tissue section shown in the lower panel in Figure 33 presented three slight folds 
at its upper-half, which could be seen in the optical image of the tissue (Figure 33E). 
The raw MALDI images of some lipids reflected this appearance (Figure 33I) while 
others did not (Figure 33F). In either cases, the internal standard-normalized images 
showed accurately the details of the surface irregularity (Figure 33H and K). 
Raw and TIC-normalized images of m/z 524.371 (LPC(18:0), [M+H]+, ∆m = 0.19 ppm) 
missed the definition of tissue folds (Figure 33F and G). Normalization to the H+ adduct 
of the PC(21:0/21:0) internal standard (Figure 33H) showed a superior image quality 
matching the optical image (Figure 33E). On the other hand, the raw image of m/z 
796.526 (PC(34:2), [M+K]+, ∆m= 0.75 ppm) reflected the tissue folds (Figure 33I). 
Normalization to K+ adduct of PC(21:0/21:0) maintained the actual state of the tissue 
(Figure 33K), and showed good agreement to the optical, raw and TIC-normalized 
images (Figure 33E, I, and J, respectively), confirming the actual condition of tissue 
section. 
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Figure 33. Upper panel: improved identification of renal structures upon correction 
to internal standard. (A) H&E image of a subsequent tissue cut. (B) Raw ion extracted 
image of m/z 758.570. (C and D) Normalized images of m/z 758.570 to TIC and 
[M+H]+ of PC internal standard at m/z 874.725. 
Lower panel: E. Optical image of another tissue. Arrows point at the exact position 
of tissue folds. MALDI images of raw (F and I), TIC-normalized (G and J) and 
PC(21:0/21:0)-normalized images (H and K) of tissue lipids at m/z 524.371 and m/z 
796.526. 
3.2.6 Application for intersample or intermeasurement correction 
MALDI imaging data of control and cisplatin-treated kidney tissues printed side by side 
was used to show the role of normalization to internal standards in terms of intersample 
comparison. In the previous part of this work (chapter 3.1), differences in the 
distribution of renal lipids demonstrated the nephrotoxic effect caused by cisplatin 
treatment[202]. In analogy to the previous results, MALDI images of tissue lipids, this 
time normalized to internal standards, showed differences in lipids distribution between 
both groups. In addition, differences in abundance caused by variations of instrumental 
performance could be successfully corrected.  
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Figure 34 illustrates raw and normalized images of two tissue lipids (m/z 524.371 
(LPC(18:0), [M+H]+, ∆m= 0.19 ppm) (Figure 34C to H), and m/z 800.461 (PE(38:7), 
[M+K]+, ∆m= 2.25 ppm) (Figure 34I to N)] with significant differences in distribution 
between control and cisplatin-treated tissues. 
The raw image of m/z 524.371 in cisplatin kidney (Figure 34D) showed a homogenous 
distribution of the lipid in cortex and outer medulla with a higher local abundance at 
the corticomedullary junction; while control kidney (section taken at a different plane, 
Figure 34C) showed a less intense outer medulla and about 2-fold higher intensity of 
the lipid at the renal cortex. Normalization to [M+H]+ of PC(21:0/21:0) at m/z 874.725 
brought the lipid abundance in the two tissues closer showing an acceptable correlation 
and confirmed the distribution already indicated in the non-normalized images (Figure 
34G and H). These findings agree well with TIC-normalized images of both tissues 
(Figure 34E and F), but internal standard-normalization ensures a more proper 
comparison of tissues with relative quantification purposes. 
The non-normalized images of the other species at m/z 800.461 (Figure 34I and J) 
showed different distribution between control and cisplatin-treated tissue as well, where 
the lipid in the cisplatin-treated kidney (Figure 34J) was located mostly in the cortex. 
In the control tissue, a homogenous distribution of the lipid with higher abundance in 
comparison to the cortex of the cisplatin-treated kidney was seen (Figure 34I). 
Normalization to the [M+K]+ of PE(15:0/15:0) at m/z 702.447 confirmed the lipid 
distribution and showed equal abundance level in the cortex and outer medulla of 
control tissue with respect to the cortex of cisplatin-treated tissue (Figure 34M and N), 
in analogy to the TIC-normalized images of both tissues (Figure 34K and L). 
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Figure 34. H&E optical images of kidney tissue sections of (A) control and (B) 
cisplatin-treated samples. Raw (C and D), TIC-normalized (E and F) and IS-
normalized (with m/z 874.725) (G and H) MALDI images are shown for LPC(18:0) 
at m/z 524.371 in control and cisplatin kidney tissues, respectively. Raw (I and J), 
TIC-normalized (K and L), m/z 702.447 IS-normalized (M and N) MALDI images 
are displayed for PE(38:7) at m/z 800.461 in control and cisplatin kidney tissues, 
respectively. 
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Changes in the mean intensity of m/z 524.371 and m/z 800.461 in different locations 
of control and cisplatin-treated tissues before and after normalization are demonstrated 
in Figure 35, showing the clear impact of normalization on intensity fold-change 
calculation. 
Intensity profiles of raw and TIC-normalized images of H+, Na+ and K+ adducts of 
PC(32:1) (([M+H]+ at m/z 732.553, ∆m= 1.10 ppm), ([M+Na]+ at m/z 754.536, ∆m= 
0.40 ppm), and ([M+K]+ at m/z 770.509, ∆m= 0.91 ppm)) are presented in Figure 36A 
to L. Additionally, internal standard-normalized images are shown in Figure 36M to R, 
where each of the H+, Na+, and K+ adducts of PC(32:1) was normalized to its 
corresponding adduct of PC(21:0/21:0) at m/z 874.725, m/z 896.707 and m/z 912.681, 
respectively.  
  
Figure 35. Raw and IS-normalized mean intensity and %RSD over 3 ROIs 
(highlighted in the MALDI images in magenta, each ROI has 75 pixel) in the cortex 
of control and cisplatin-treated tissues for m/z 524.371 and m/z 800.461. 
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The raw images of the H+, Na+, and K+ adducts of PC(32:1) in control kidney showed 
a homogenous tissue distribution (Figure 36A, C, E) in contrast to cisplatin-treated 
tissue (Figure 36B, D, F), where different local intensities (cortex > outer medulla > 
inner medulla) could be found for the lipid. The difference in distribution in both tissues 
was confirmed in TIC- and internal standard-normalized images. In addition, the false 
enhancement of intensity of H+, Na+, and K+ adducts in control kidney (Figure 36A, C, 
E) in comparison to the same adducts in the cisplatin-treated tissue (Figure 36B, D, F), 
could be successfully corrected in the TIC- and internal standard-normalized images, 
similarly to Figure 34. 
More importantly, raw and TIC-normalized images of both tissues showed different 
signal levels of the H+, Na+, and K+ adducts of PC(32:1) (with [M+Na]+> [M+K]+> 
[M+H]+) [raw: (control: Figure 36C > E > A) , (cisplatin: Figure 36D > F > B), TIC-
normalized: (control: Figure 36I > K > G), (cisplatin: Figure 36J > L > H)]. However, 
internal standard-normalization showed in a unique manner that the lipid images for the 
three adduct types are almost identical not only for control (Figure 36M, O, Q), but also 
for cisplatin-treated tissue (Figure 36N, P, R). This suggests that normalization based 
on the same adduct type offers a more realistic and comparable intensity levels of the 
lipids in tissues. 
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Figure 36. I. H&E optical images of subsequent kidney tissue section of control and 
cisplatin-treated samples. II. MALDI MSI data showing raw ions intensity (A to F). 
III. TIC-normalized ions intensity (G to L). IV. Internal standard-normalized ions 
intensity of H+, Na+ and K+ adducts of PC(32:1) at m/z 732.553, m/z 754.536,  m/z 
770.509 , respectively (M to R). 
3.2.7 Conclusion and outlook 
An accurate, robust and reproducible method for controlled automatic printing of 
matrix and dual internal standards was developed, to normalize MALDI MSI data of 
kidney lipids. Reproducibility and homogeneity of matrix and internal standards 
deposition were demonstrated, this being controlled with a secondary internal metal 
standard spiked to the printing mixture and analyzed by ICP-MS. Normalization to the 
primary internal lipid standards offered excellent correction results with respect to 
possible variability of laser energy deposition observed in lengthy MALDI MSI tissue 
measurements. Optimum results were obtained upon normalizing a specific lipid adduct 
to internal standard adduct of a similar ion type and chemical class. 
The method was successfully applied to normalize ion intensities of kidney lipids in 
control and cisplatin-treated rats allowing improved correlation of relative lipids 
abundance in both groups. Our results highlight the importance of controlled 
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homogenous matrix-internal standards application for reliable relative quantification of 
endogenous species in imaging studies. For intersample assessment of lipids 
abundances, comparisons based on normalizing the intensity of the lipid adduct of 
interest to the intensity of internal standard adduct of the same type are highly 
recommended. In addition, we recommend considering normalized intensities of 
different adducts of the same lipid species, where possible, as this draws a realistic view 
of the species relative abundance. We also foresee the use of multimolecular internal 
lipid standards extended to a wider range of lipid classes to be of great potential for 
MALDI imaging of tissue lipids, enabling improved pixel-based normalization of 
different lipids classes simultaneously. 
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4 Materials and methods 
Instrument type Model Manufacturer 
MALDI LTQ orbitrap MALDI LTQ Orbitrap 
XLTM 
Thermo Scientific, San José, 
CA, USA 
Sector field ICP-MS  Element XR Thermo Fisher Scientific, 
Germany 
Nebulizer MicroMist Glass Expansion, Melbourne, 
Australia 
Laser ablation system 
(LA) 
UP-213 ESI, Portland, USA 
Air brush Aztek® A4709 Airbrush 
Set  
The Testor Corp., USA 
Balance Sartorius CP225D Sartorius 
Inkjet printer Pixma iP7250 Canon, Germany 
Microscope inverted IX70 microscope Olympus, Hamburg, 
Germany 
Digital microscope 
camera  
dnt® USB microscope 
(5 Mega Pixels, maximum 
Magnification Ratio ca. 
300x) 
DigiMicro Profi, Germany 
Cryostat HM525 NX Thermo Fisher Scientific,  
Table 3. Analytical instruments and equipment 
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Instrument type Model Manufacturer 
Non-conductive glass 
slides 
Superfrost Plus Thermo Fisher Scientific, 
Braunschweig, Germany 
MALDI target sample 
plate 
Sample Plate Kit (P/N 
97155-62033) 
Thermo Scientific, San José, 
CA, USA 
Scanner HP Scanjet G4050 - 
Fotoscanner 
HP Development Company, 
Germany 
Nitrocellulose 
membranes 
Protran® BA85 Whatman® , Dassel, 
Germany 
4.1 Lipid imaging by MALDI LTQ Orbitrap mass spectrometry 
in kidney sections under cisplatin treatment 
4.1.1 Chemicals and reagents 
Solutions were prepared using ultrapure water (Milli-Q water purification system, 
Millipore, Bedford, MA). MALDI matrices (2,5-dihydroxybenzoic acid (DHB) and α-
cyano-4-hydroxycinnamic acid (α-CHCA)), methanol (MeOH), acetonitrile (ACN) and 
trifluoroacetic acid (TFA) were purchased from Sigma-Aldrich (Steinheim, Germany). 
Cisplatin was obtained from Pharmacia Nostrum S.A. (Madrid, Spain) and was 
dissolved in 0.9% NaCl solution (Braun Medical S.A, Barcelona, Spain) for 
administration. Purchased chemicals were used without further purification. 
4.1.2 Animal treatment and tissue preparation 
Animals were treated at the laboratories of the Health Research Institute Gregorio 
Marañón hospital (Madrid, Spain). Experiments were approved by the hospital 
committee of ethics on animal experimentation (EAEC). Animals were cared for 
following applicable legal regulations in the European Directive 2010/63/UE on the 
protection of animals used for experimentation and other scientific purposes. 
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As previously described in [202], two groups of 7 week old female Wistar rats (Criffa, 
Barcelona, Spain), were kept under controlled conditions of light (12-h light/dark 
cycle), humidity, and temperature with food and water. Daily intraperitoneal injection 
(i.p.) of control and cisplatin-treated groups was carried out[175, 207]. Cisplatin was 
dissolved in 0.9% NaCl and administered at 5 mg kg−1 body weight in a single dose, 
while control group received only 0.9% NaCl. Animals were sacrificed after five days 
of treatment. Kidneys were perfused in ice-cold saline, shock frozen in liquid nitrogen, 
and stored at -80 °C. Cryosectioning (Thermo Fisher Scientific, HM525 NX) of the 
frozen kidneys to obtain 10 um sections was carried out. Non-conductive glass slides 
(Superfrost plus, Thermo Fisher Scientific, Braunschweig, Germany) were used for 
mounting of tissue sections[208]. The prepared sections were stored at -80 °C. Before 
matrix was applied, samples were taken out of the freezer to a desiccator where they 
were allowed to equilibrate to room temperature for 30 minutes, then optical images of 
the tissues were kept for reference. 
4.1.3 Histological hematoxylin and eosin staining 
Parallel sagittal sections of rat kidneys (5 µm) were stained with hematoxylin and eosin 
((HE, Sigma-Aldrich, St. Louis, MO). Optical images of the stained samples at 20x 
magnification were for histological examination using an inverted Olympus IX70. 
4.1.4 MALDI matrices 
For positive ion mode MALDI lipid imaging, different concentrations of α-CHCA and 
DHB were tested in control vehicle kidney sections (Table 4). 
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Matrix Concentration (mg 
mL−1) 
Solvent  Structure 
DHB 20, 40, 60 70% MeOH, 0.1% 
TFA 
 
α-CHCA 10,  20 60% ACN, 0.1% 
TFA 
 
4.1.5 Matrix application 
An in-house airbrush was used at a flow rate of 350 µL min−1 (measured with iPrOH). 
The airbrush was held at 20 cm distance to the target slide in a fume hood using a stand 
clamp. For calibration, the spray controller was adjusted to a spray cone of 1.5 cm 
diameter at 1.85 bar of the argon gas pressure (Figure 37). The airbrush was used to 
apply 10–35 cycles of matrix aerosol. Each spray cycle lasts for 20–40 s, followed by 
drying time for 20 or 40 s for DHB and CHCA, respectively. 
During optimization of matrix deposition, tissues were partially covered with paper, as 
required, for the application of different deposition cycles within each tissue section. 
Table 4. Name, concentrations, solvents used, and structures of matrices tested for 
optimization in MALDI MSI tissue measurements. 
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Figure 37. Airbrush used for matrix application showing functional parts used for its 
calibration. 
4.1.6 Instrumentation 
All MALDI MSI measurements and direct on-tissue MS/MS analysis in this thesis were 
carried out on a hybrid linear ion trap/orbitrap mass spectrometer fitted with a MALDI 
ion source that operates at intermediate pressure (MALDI LTQ Orbitrap XL, Thermo 
Fisher Scientific, Bremen, Germany). Instrument was calibrated using ProteoMassTM 
MALDI Calibration Kit for LTQ XLTM and LTQ Hybrids (Sigma Aldrich, St. Louis, 
USA). Automatic gain control of the LTQ XL (AGC) was turned on during the imaging 
experiments, and the nitrogen laser (337 nm, 3 ns, 60 Hz, (LTB, Berlin, Germany)) was 
tuned manually to obtain 10-15 laser shots per pixel on tissue (typically adjusted to: 20 
µJ for CHCA, 40 µJ for DHB). Tissues were scanned in a horizontal raster mode with 
a lateral resolution between 100-500 µm in a meandering pattern with a laser spot 
diameter of 80 × 60 µm. Full-scan mass spectra were collected in positive ion mode 
averaging 2 microscans per step at m/z 150–2000 Da mass range. The mass resolving 
power was set to 60 000 on the FT MS analyzer. 
On-tissue MS/MS experiments were performed in the ion trap by collision-induced 
dissociation (CID) at 35% energy to confirm the identification of major lipids based on 
neutral losses and characteristic fragments of the head group. 
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Xcalibur and ImageQuest software (Thermo Scientific, Germany) were used to analyze 
the data and create MALDI MSI images, which were extracted with a 0.005 Da 
tolerance and normalized against total ion count (TIC). 
4.1.7 Molecular identification and nomenclature of tissue lipids  
Identification of lipids was done based on accurate mass assignment of the precursor 
ion using the exact mass search in LipidMaps[209] with a mass window of 5 ppm. 
Manual interpretation of fragmentation patterns from MS/MS experiments was 
performed with the aid of LipidMaps tools. According to LipidMaps, lipids were 
assigned as follows:  
Glycerophospholipids [PC, PE, PI, PG, lyso-PC (LPC)], species are followed by X:Y, 
where X is the total length of the acyl chains and Y represents the total number of 
double bonds. Sphingolipids (Cer and SM), species are designated by W:Z, where W 
is the total length of the acyl chain bound to the sphingosine, and Z is the amount of the 
chain double bonds. “O-” and “P-” designate alkyl ether linkage and (1Z)-alkenyl ether, 
respectively; while in sphingolipids, “h”, “d” and “t” indicate hydroxy, 1,3-dihydroxy 
and 1,3,4-trihydroxy, respectively, long chain bases. 
4.2 Dual internal standards with metals and molecules for 
MALDI imaging of kidney lipids 
4.2.1 Chemicals  
Standard phospholipids, 1,2-dipentadecanoyl-sn-glycero-3-phosphoethanolamine (PE 
(15:0/15:0)) and 1,2-diheneicosanoyl-sn-glycero-3-phosphocholine (PC(21:0/21:0)) 
were purchased from Avanti Polar Lipids Inc. Solutions were prepared using ultrapure 
water (Milli-Q water purification system, Millipore, Bedford, MA). Chloroform 
(CHCl3), methanol (MeOH) and trifluoroacetic acid (TFA) were purchased from Carl 
Roth GmbH + Co. KG (Karlsruhe, Germany). MALDI matrix, 2,5-dihydroxybenzoic 
acid (DHB) was purchased from Sigma-Aldrich (Steinheim, Germany). For ICP-MS 
analysis, single-element (141Pr (Pr6O11, in 2%HNO3) and 169Tm (TmCl3, in 2%HNO3)) 
and multi-element standard solution for ICP and nitric acid (ultraquality, 69%) were 
obtained from Carl Roth, Germany. Purchased chemicals were used without further 
purification. 
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4.2.2 Animals treatment and tissue preparation 
Control and cisplatin-treated 7 weeks old Wistar rats were obtained from the 
laboratories of the Instituto de Investigación Sanitaria Gregorio Marañón (IISGM, 
Madrid, Spain) following the same protocol described previously in this work[175, 202, 
207]. Frozen kidney tissues from control and cisplatin-treated groups were 
cryosectioned (Thermo Fisher Scientific, HM525 NX) to produce 10 µm sections, 
which were mounted on non-conductive glass slides (Superfrost plus, Thermo Fisher 
Scientific, Braunschweig, Germany) and stored at -80 °C until further use. Before 
printing, tissue sections were taken out of the freezer to a desiccator where they were 
allowed to stand for 30 minutes. Optical scans of the samples were kept for reference 
(HP Scanjet G4050 - Fotoscanner). In addition, parallel 5 µm saggital sections were 
stained with hematoxylin and eosin (HE, Sigma-Aldrich, St. Louis, MO) and examined 
with 20x magnification using an inverted IX70 microscope (Olympus, Hamburg, 
Germany). 
4.2.3 Matrix- internal standards mixture preparation 
The printing mixture included DHB as MALDI matrix (120 mg mL-1 in 70% MeOH, 
0.1% TFA), in addition to two non-endogenous phospholipids as primary lipidic 
internal standards (Table 5), PC (21:0/21:0) and PE (15:0/15:0) in a final concentration 
of 300 mg L-1, and a monoisotopic lanthanide, thulium (169Tm) in a final concentration 
of 1 mg L-1 as a secondary internal standard. Freshly prepared matrix-internal standards 
mixture was used for each printing experiment. 
Each of PC (21:0/21:0) and PE (51:0/51:0) was prepared separately in 6000 mg L-1 
stock solution in Chloroform : Methanol: Water in the ratio (C:M:W → 65:40:8). 
Stability of the lipidic standards was controlled by MALDI spot measurements to 
screen for decomposition. Lipids stocks were consumed over a maximum of 1-month 
interval. 
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PE (15:0/15:0) 
1,2-dipentadecanoyl-sn-glycero-3-phosphoethanolamine 
Molecular formula: C35H70NO8P 
Exact mass: 663.484 
 
PC (21:0/21:0) 
1,2-diheneicosanoyl-sn-glycero-3-phosphocholine 
Molecular formula: C50H100NO8P 
Exact mass: 873.719 
 
4.2.4 Inkjet printing of matrix-internal standards mixture 
The mixture containing the matrix and the internal standards was applied to the tissue 
sections using a conventional inkjet desktop printer (Pixma iP7250, Canon, Germany). 
As previously described in [204, 205], the customized ink (matrix-internal standards 
mixture) was fed to empty cartridges using a syringe. Settings for disk printing were 
selected and the CD-tray holder was modified to adapt two glass slides, which were 
passed through the printer for 30 times, each corresponds to a printing cycle. Print 
quality was set to ‘’high’’. 
To equilibrate the printer, 10 sheets of A4 papers were printed.  Glass slides were heated 
briefly for 5 s at 45 C° before each printing cycle, the quality of printing was monitored 
visually using a digital microscope camera (dnt® DigiMicro Profi, Germany). 
O O
P O
O
O H
O
O
-
O N
+
Table 5. Structure, chemical name, molecular formula, and exact mass of PE 
(15:0/15:0) and PC (21:0/21:0). 
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4.2.5 MALDI MSI measurements 
MALDI LTQ Orbitrap XLTM (Thermo Scientific, Germany) was used for high 
resolution MSI analysis. Laser energy was manually tuned to obtain 10-15 laser shots 
per pixel on tissue. Tissues were scanned in a horizontal raster mode with a lateral 
resolution of 100 µm in a meandering pattern with a laser beam size of 80×60 µm. Full 
scan positive ion mass spectra were registered averaging 2 microscans per step at m/z 
150–2000 Da mass range, and a mass resolution of 60000 was used on the FT MS 
analyzer. Lipids were assigned using the exact mass search in LipidMaps[209] based 
on the accurate mass of the precursor ion with a mass tolerance of 5 ppm and some 
assignments were confirmed by on-tissue MS/MS analysis[202]. 
For image creation and data analysis, ImageQuest 1.0.1 (Thermo Scientific, Germany), 
and the open-source MS imaging software, MSiReader[91] were used. With the raw-
to-imzML-converter[93], the standard Thermo data file format (.raw) was reformatted 
into the (.imzML) file format, which is supported by MSiReader software. Images were 
extracted with a mass window of 5 ppm, and saved as TIFF file. Image normalization 
was done by dividing the signal of the tissue lipids of interest by that of the internal 
standards in each point. 
4.2.6 Direct injection and laser ablation ICP-MS analysis  
Nitrocellulose membranes (NC) (Whatman® Protran® nitrocellulose membranes, 
Dassel, Germany) of approximately 10x10 mm were fixed to glass slides next to the 
tissue sections and printed simultaneously. The printed membranes were collected and 
used for direct infusion ICP-MS as well as LA-ICP-MS. 
Direct infusion ICP-MS 
The collected NC membranes were weighed and digested in 150 µL 69% HNO3 
(HNO3, ultraquality, Carl Roth, Germany) for direct injection ICP-MS analysis. 
Digested samples were diluted in a ratio of 1:10 in 3.5% HNO3 including 10 µL Pr (100 
µg L-1) as internal standard to a final volume of 500 µL. For external calibration, a 
solution series from 20 ng L-1 to 10 µg L-1 using Tm standard solution was prepared. 
The sector field (Element XR, Thermo Fisher Scientifc, Bremen, Germany) was 
connected to a Meinhard-type nebulizer with a cyclonic spray chamber (MicroMist, 
Glass Expansion, Melbourne, Australia) using a nebulizer gas flow rate of 1.0 L min-1 
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Ar. The instrument was operated at plasma gas flow of 15 L min-1, auxiliary gas flow 
of 1.00 L min-1, and RF plasma power of 1250 W. 
LA-ICP-MS 
LA-ICP-MS analysis was performed on a commercial LA system (UP-213, ESI, 
Portland, USA) coupled to the ICP-MS (Element XR, Thermo Fisher Scientific, 
Bremen, Germany). The ICP-MS was synchronized using the LA unit in an external 
trigger mode. The operating conditions are shown in Error! Reference source not 
found.. The ICP-MS operating conditions were tuned daily for maximum intensity and 
low oxide ratio ((ThO/Th) < 0.7%) using a reference glass slide (SRM 612, NIST, 
Maryland USA). The printed nitrocellulose membranes were ablated continuously in 
line scans. Overlapping line scans and high laser shot repetition rates were applied to 
ensure complete ablation of the membrane sample. 
Mass traces of 169Tm were recorded at low resolution (R=300). The analysis of a 
nitrocellulose membrane (with 2×2 mm average dimensions) required about 20 min. 
Data was exported to Origin 2016 (OriginLab Corporation, Northampton, MA) where 
generation of color coded images was performed.  
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Table 6. Instrumental parameters of the LA-ICP-MS measurements. 
ICP-MS LA system 
RF plasma power 1257 W Wavelength 213 nm 
Plasma gas flow (Ar) 15 L min-1 Helium gas flow 0.8 L min-1 
Sample gas flow (Ar) 1.3 L min-1 Laser energy 100% (5.16 J cm-2) 
Auxiliary gas flow (Ar) 0.99 L min-1 Laser spot size 100 µm 
Mass resolution 
(m/∆m) 
300 (LR) Scan speed 100 µm s-1 
Sample time 2 ms Repetition rate 20 Hz 
Scanning mode E scan Line overlapping 20% 
Detected isotope 169Tm   
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5 Abbreviations 
Abbreviation Full name 
ACN     Acetonitrile 
AP MALDI  Atmospheric pressure matrix-assisted laser desorption ionization  
α-CHCA    α-cyano-4-hydroxycinnamic acid 
CID     Collision-induced dissociation 
CMC     Carboxymethylcellulose 
CPCD     Coupled physical and chemical dynamics model 
DC      Direct current 
DESI    Desorption electrospray ionization 
DHB     2,5-dihydroxybenzoic acid 
DHSM    Dihydroxysphingomyelin 
DHCer    Dihydroxyceramide  
ELISA    Enzyme-linked immunosorbent assays 
ESI-MS    Electrospray ionization mass spectrometry 
FDR     False discovery rate 
FFT      Fast Fourier Transformation 
FFPE     Formalin-fixed paraffin-embedded 
FTICR    Fourier transform ion cyclotron resonance 
GC       Gas chromatography 
GPLs    Glycerophospholipids 
h      Hour 
H&E     Hematoxilin-eosin 
HMDB     Human Metabolome Database 
HPLC    High-performance liquid chromatography  
HRMS    High Resolution MS 
ICP-MS    Inductively coupled plasma mass spectrometry 
iPrOH    Isopropanol   
IP      Ionization potential 
i.p.     Intraperitoneal 
ITO     Indium tin oxide 
LA-ICP    Laser ablation inductively coupled plasma 
LC      Liquid chromatography  
LMSD     Lipid Maps Structure Database 
LTQ     Linear trap quadropole 
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LAESI    Laser ablation electrospray ionization 
LESA    Liquid extraction surface analysis 
LMSD    Lipid Maps Structure Database 
LPC or lyso-PC Lysophosphatidylcholines 
MALDI MSI  Matrix-assisted laser desorption ionization mass spectrometry 
imaging  
MALDI-TOF  Matrix-assisted laser desorption ionization time of flight 
MeOH    Methanol 
MSI     Mass spectrometry imaging 
MS     Mass spectrometry 
MS/MS    Tandem mass spectrometry 
MSM    Metabolite-signal match 
MRI     Magnetic Resonance Imaging 
m/z     Mass-to-charge ratio 
NC     Nitrocellulose 
NL     Neutral loss 
NMR     Nuclear magnetic resonance 
NPLC    Normal-phase liquid chromatography 
ns      Nanosecond 
OCT     Optimal cutting temperature 
PC     Phosphatidylcholine 
PE     Phosphatidylethanolamine    
PI      Phosphatidylinositol 
PCA     Principal component analysis 
PUFAs    Polyunsaturated fatty acids 
RPLC    Reversed-phase liquid chromatography 
RF     Radiofrequency  
SA      sinapic acid, 3,5-dimethoxy-4-hydroxycinnamic acid 
SIMS    Secondary ion mass spectrometry 
SM     Sphingomyelin 
s       Second 
TFA     Trifluoroacetic acid  
TLC      Thin-layer chromatography 
TOF     Time of flight 
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